WO2023063168A1 - Pest controlling composition - Google Patents

Pest controlling composition Download PDF

Info

Publication number
WO2023063168A1
WO2023063168A1 PCT/JP2022/037122 JP2022037122W WO2023063168A1 WO 2023063168 A1 WO2023063168 A1 WO 2023063168A1 JP 2022037122 W JP2022037122 W JP 2022037122W WO 2023063168 A1 WO2023063168 A1 WO 2023063168A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
substituents
control composition
pest control
optionally
Prior art date
Application number
PCT/JP2022/037122
Other languages
French (fr)
Japanese (ja)
Inventor
秀幸 池内
昭佳 山内
洋介 岸川
Original Assignee
ダイキン工業株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ダイキン工業株式会社 filed Critical ダイキン工業株式会社
Publication of WO2023063168A1 publication Critical patent/WO2023063168A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00Fungicides
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00Arthropodicides
    • A01P7/04Insecticides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Definitions

  • the present disclosure primarily relates to pest control compositions.
  • Clofarabine is a second-generation purine antagonist classified as a nucleic acid analog antimetabolite. Clofarabine is converted to active clofarabine triphosphate by intracellular enzymes, and by inhibiting both ribonucleotide reductase and DNA polymerase ⁇ , it inhibits DNA synthesis and repair in leukemia cells. induce death. Evoltra (trademark) intravenous infusion 20 mg containing clofarabine as an active ingredient has been developed, and its manufacture and sale has been approved for its efficacy in treating "relapsed or refractory acute lymphocytic leukemia" (Non-Patent Document 1).
  • An object of the present disclosure is to provide a composition useful for controlling pests.
  • R 1 and R 2 are each independently hydrogen, a hydrocarbon group optionally having one or more substituents, R 3 CO—, or a sulfamoyl group;
  • R 3 is a hydrocarbon group optionally having one or more substituents,
  • X is hydrogen, halogen, nitro group, cyano group, hydrocarbon group optionally having one or more substituents, heteroaryl group, R 4 O—, R 5 S—, or R 6 R 7 N - and R 4 , R 5 , R 6 and R 7 are each independently hydrogen or a hydrocarbon group optionally having one or more substituents,
  • Z is hydrogen, halogen, an azide group, a cyano group, or R 8 O—;
  • R 8 is a hydrocarbon group optionally having one or more substituents.
  • Section 2. Item 2. The pest control composition according to Item 1, wherein R 1 and R 2 are each independently hydrogen or R 3 CO-. Item 3.
  • Item 3. The pest control composition according to Item 1 or 2, wherein R3 is an alkyl group optionally having one or more substituents. Section 4.
  • X is hydrogen, halogen, nitro group, cyano group, alkyl group, alkenyl group, alkynyl group, cycloalkyl group, aryl group, heteroaryl group, R 4 O—, R 5 S—, or R 6 R 7 N— and R 4 , R 5 , R 6 and R 7 are each independently hydrogen or an alkyl group optionally having one or more substituents;
  • Item 4. The pest control composition according to any one of items 1 to 3.
  • Item 5. The pest control composition according to any one of Items 1 to 4, wherein X is a halogen, a cyano group, or R 4 O-.
  • R 1a and R 2a are each independently a hydrocarbon group optionally having one or more substituents, R 3a CO—, or a sulfamoyl group, R 3a is a hydrocarbon group optionally having one or more substituents, X a is a halogen, a nitro group, a cyano group, a hydrocarbon group optionally having one or more substituents, a heteroaryl group, R 4a O—, or R 5a S—; R 4a and R 5a are each hydrogen or a hydrocarbon group optionally having one or more substituents, Z a is a halogen, an azide group, a cyano group, or R 8a O—; R 8a is a hydrocarbon group optionally having one or more substituents. ) A compound represented by or a salt thereof.
  • compositions useful for controlling pests are provided.
  • room temperature can mean a temperature within the range of 10-40°C.
  • C nm (where n and m are each positive integers and n ⁇ m) means that the number of carbon atoms is It represents n or more and m or less.
  • hydrocarbon group means a group consisting only of carbon and hydrogen.
  • examples of the "hydrocarbon group” include (1) an aliphatic hydrocarbon group optionally substituted with one or more aromatic hydrocarbon groups (aryl groups), and (2) one or more aliphatic hydrocarbon Aromatic hydrocarbon groups optionally substituted with groups are included.
  • a “hydrocarbon group” can have a structure that is linear, branched, cyclic, or a combination thereof.
  • aliphatic hydrocarbon group can be saturated or unsaturated.
  • examples of “aliphatic hydrocarbon groups” include alkyl groups, alkenyl groups, alkynyl groups, cycloalkyl groups, and cycloalkenyl groups.
  • alkyl group examples include linear or branched C 1-12 alkyl groups, and specific examples thereof include methyl, ethyl, and propyl groups (eg, n- propyl group, isopropyl group), butyl group (eg n-butyl group, isobutyl group, sec-butyl group, tert-butyl group), pentyl group (eg n-pentyl group, tert-pentyl group, neopentyl group, isopentyl group, sec-pentyl group, 3-pentyl group), hexyl group, heptyl group, octyl group, nonyl group, and decyl group.
  • propyl groups eg, n- propyl group, isopropyl group
  • butyl group eg n-butyl group, isobutyl group, sec-butyl group, tert-butyl group
  • alkenyl group examples include linear or branched C 2-10 alkenyl groups, and specific examples thereof include vinyl, 1-propenyl, isopropenyl, 2 -methyl-1-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 2-ethyl-1-butenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl 4-methyl-3-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, and 5-hexenyl groups.
  • alkynyl group examples include linear or branched C 2-10 alkynyl groups, and specific examples thereof include ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-hexynyl group, 2-hexynyl group, 3-hexynyl group, 4-hexynyl groups and 5-hexynyl groups are included.
  • cycloalkyl group examples include C 3-10 cycloalkyl groups, and specific examples thereof include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl and adamantyl groups.
  • cycloalkenyl groups include C 3-10 cycloalkenyl groups, and specific examples thereof include cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl, and cycloheptenyl groups. contain.
  • an "aromatic hydrocarbon group (aryl group)” can be, for example, monocyclic, bicyclic, tricyclic, or tetracyclic.
  • aromatic hydrocarbon group include C 6-14 aromatic hydrocarbon groups, and specific examples thereof include phenyl, 1-naphthyl, 2-naphthyl, 2-biphenyl, 3- It includes biphenyl groups, 4-biphenyl groups, and 2-anthryl groups.
  • examples of the aliphatic hydrocarbon group substituted with the aromatic hydrocarbon group include arylalkyl groups (aralkyl groups), and specific examples thereof include benzyl group, phenethyl group, diphenylmethyl group, 1-naphthylmethyl group, 2-naphthylmethyl group, 2,2-diphenylethyl group, 3-phenylpropyl group, 4-phenylbutyl group, 5-phenylpentyl group, 2-biphenylmethyl group, 3-biphenylmethyl and C 7-15 aralkyl groups such as the 4-biphenylmethyl group.
  • substituents that can be substituted on hydrocarbon groups include halogens, hydroxyl groups, mercapto groups, amino groups, alkoxy groups, alkylthio groups, monoalkylamino groups, and dialkylamino groups.
  • halogen in this specification include fluorine, chlorine, bromine, and iodine.
  • alkoxy group can be a group represented by RO-- (wherein R is an alkyl group).
  • alkoxy group include linear or branched C 1-12 alkoxy group, and specific examples thereof include methoxy group, ethoxy group, propoxy group (e.g. n-propoxy group, isopropoxy group ), butoxy, pentyloxy, and hexyloxy groups.
  • alkylthio group can be a group represented by RS- (wherein R is an alkyl group).
  • R is an alkyl group.
  • alkylthio group include linear or branched C 1-12 alkylthio groups, and specific examples thereof include methylthio, ethylthio, propylthio (e.g. n-propylthio, isopropylthio ), butylthio, pentylthio, and hexylthio groups.
  • a "monoalkylamino group” can be a group represented by R-NH- (wherein R is an alkyl group).
  • Examples of “monoalkylamino group” include monolinear or branched C 1-12 alkylamino groups, and specific examples thereof include monomethylamino group, monoethylamino group, monopropylamino group (e.g. : mono n-propylamino group, monoisopropylamino group), and monobutylamino group.
  • a “dialkylamino group” can be a group represented by R 2 N-- (in the formula, each of the two R's is independently an alkyl group).
  • dialkylamino group examples include dilinear or branched C 1-12 alkylamino groups, and specific examples thereof are dimethylamino group, diethylamino group, ethylmethylamino group, dipropylamino group (eg, di-n-propylamino group, diisopropylamino group) and methylpropylamino group (eg, methyl n-propylamino group, methylisopropylamino group).
  • the “aromatic heterocyclic group (heteroaryl group)” can be, for example, monocyclic, bicyclic, tricyclic, or tetracyclic, and has 5 to 18 members, 5 to 16 5-14 membered, or 5-12 membered.
  • Examples of the “aromatic heterocyclic group” include 5- or 6-membered monocyclic aromatic heterocyclic groups and 5- to 18-membered aromatic condensed heterocyclic groups.
  • examples of the "5- or 6-membered monocyclic aromatic heterocyclic group” include a pyrrolyl group (eg, 1-pyrrolyl group, 2-pyrrolyl group, 3-pyrrolyl group), a furyl group (eg: 2-furyl group, 3-furyl group), thienyl group (e.g. 2-thienyl group, 3-thienyl group), pyrazolyl group (e.g.
  • pyridyl group e.g., 2-pyridyl group, 3-pyridyl group, 4-pyridyl group
  • pyridazinyl group e.g., 3-pyridazinyl group, 4-pyridazinyl group
  • pyrimidinyl group e.g., 2- pyrimidinyl group, 4-pyrimi
  • examples of the "5- to 18-membered aromatic condensed heterocyclic group” include isoindolyl groups (e.g., 1-isoindolyl group, 2-isoindolyl group, 3-isoindolyl group, 4-isoindolyl group, 5-isoindolyl group, 6-isoindolyl group, 7-isoindolyl group), indolyl group (e.g., 1-isoindolyl group, 2-isoindolyl group, 3-isoindolyl group, 4-isoindolyl group, 5-isoindolyl group, 6-isoindolyl group, 7-isoindolyl group), indolyl group (e.g., 1-isoindolyl group, 2-isoindolyl group, 3-isoindolyl group, 4-isoindolyl group, 5-isoindolyl group, 6-is
  • 1-benzo[c]thienyl group, 4-benzo[c]thienyl group, 5-benzo [c] thienyl group), indazolyl group e.g., 1-indazolyl group, 2-indazolyl group, 3-indazolyl group, 4-indazolyl group, 5-indazolyl group, 6-indazolyl group, 7-indazolyl group
  • benzimidazolyl group e.g. 1-benzimidazolyl group, 2-benzimidazolyl group, 4-benzimidazolyl group, 5-benzimidazolyl group
  • 1,2-benzisoxazolyl group e.g.
  • imidazo[1,2-a]pyridin-2-yl group imidazo[1,2- a]pyridin-3-yl group, imidazo[1,2-a]pyridin-5-yl group, imidazo[1,2-a]pyridin-6-yl group, imidazo[1,2-a]pyridine-7 -yl group, and imidazo[1,2-a]pyridin-8-yl group).
  • R 1 and R 2 are each independently preferably hydrogen, a hydrocarbon group optionally having one or more substituents, or R 3 CO—, hydrogen, 1 an alkyl group optionally having one or more substituents, an aryl group optionally having one or more substituents, an aralkyl group optionally having one or more substituents, or R 3 It is more preferably CO—, more preferably hydrogen, an alkyl group optionally having one or more substituents, or R 3 CO—, and hydrogen, an alkyl group, or R 3 CO— is even more preferred, and hydrogen or R 3 CO— is particularly preferred.
  • R 1 and R 2 are preferably the same group.
  • R 3 is an alkyl group optionally having one or more substituents, an aryl group optionally having one or more substituents, or It is preferably an aralkyl group that may have one or more substituents, more preferably an alkyl group that may have one or more substituents, or an aryl group that may have one or more substituents.
  • An alkyl group which may have one or more substituents is preferred, and more preferred.
  • the substituent is preferably a hydroxyl group, a mercapto group, an alkoxy group, or an alkylthio group, more preferably an alkoxy group or an alkylthio group, and even more preferably an alkoxy group.
  • the number of such substituents is selected from one or more and less than or equal to the maximum substitutable number, and is preferably one or two.
  • X is hydrogen, halogen, nitro group, cyano group, alkyl group, alkenyl group, alkynyl group, cycloalkyl group, aryl group, heteroaryl group, R 4 O—, R 5 S—, or R It is preferably 6 R 7 N—, more preferably halogen, a cyano group, or R 4 O—, still more preferably halogen, and even more preferably fluorine, chlorine, or bromine.
  • R 4 , R 5 , R 6 and R 7 are each independently hydrogen, an alkyl group optionally having one or more substituents, a or an aralkyl group optionally having one or more substituents, hydrogen, an alkyl group optionally having one or more substituents, or 1 It is more preferably an aryl group optionally having one or more substituents, more preferably hydrogen or an alkyl group optionally having one or more substituents, hydrogen or alkyl is even more preferred.
  • Z is preferably halogen, more preferably fluorine.
  • R 8 is an alkyl group optionally having one or more substituents, an aryl group optionally having one or more substituents, or It is preferably an aralkyl group that may have one or more substituents, more preferably an alkyl group that may have one or more substituents, or an aryl group that may have one or more substituents.
  • An alkyl group optionally having one or more substituents is preferred, and an alkyl group is even more preferred.
  • R 1 and R 2 are each independently hydrogen or R 3 CO—, and R 3 may have one or more substituents (eg, alkoxy group) It is an alkyl group, and X and Z are each independently preferably halogen. In such embodiments, it is further preferred that X is fluorine.
  • the compound represented by formula (1) or a salt thereof is preferably a compound or a salt thereof selected from the group consisting of the following formulas (1-1) to (1-12).
  • the salt of the compound represented by formula (1) may be an acid addition salt or a base addition salt.
  • the acid addition salt may be an inorganic acid salt or an organic acid salt.
  • the inorganic acid salts include salts with hydrochloric acid, sulfuric acid, phosphoric acid, hydrobromic acid, hydroiodic acid, nitric acid, pyrosulfuric acid, and metaphosphoric acid.
  • the organic acid salts include salts with citric acid, benzoic acid, acetic acid, propionic acid, fumaric acid, maleic acid, and sulfonic acid (eg, methanesulfonic acid, p-toluenesulfonic acid, and naphthalenesulfonic acid). contain.
  • Examples of the base addition salts include alkali metal salts such as sodium salts and potassium salts.
  • the method for producing the compound represented by formula (1) or a salt thereof is not particularly limited.
  • the compound represented by formula (2) is converted to It is preferable to include a step A of reacting with a compound that
  • R 1b and R 2b are each independently a hydroxyl-protecting group, Halo is a halogen, and X and Z are the same as above.
  • R 1b and R 2b are each independently an ether-type protecting group (eg, t-butyl group, benzyl group, trityl group), an acetal-type protecting group (eg, tetrahydropyranyl group), acyl type protecting group (eg, acetyl group, benzoyl group), and silyl ether type protecting group (eg, t-butyldimethylsilyl group).
  • ether-type protecting group eg, t-butyl group, benzyl group, trityl group
  • an acetal-type protecting group eg, tetrahydropyranyl group
  • acyl type protecting group eg, acetyl group, benzoyl group
  • silyl ether type protecting group eg, t-butyldimethylsilyl group
  • Halo is preferably bromine or chlorine.
  • the amounts of the compound represented by formula (2) and the compound represented by formula (3) are not particularly limited as long as the reaction proceeds.
  • the lower limit of the ratio (molar ratio) of the amount of the compound represented by formula (3) to the amount of the compound represented by formula (2) is, for example, 0.1, 0.5, or 1. can.
  • the upper limit of the ratio can be 10, 9, 8, 7, 6, or 5, for example.
  • the ratio can be, for example, 0.1-10, 0.5-8, or 1-5.
  • the reaction in step A is preferably carried out in the presence of a base.
  • bases include non-nucleophilic bases, and specific examples thereof include metal hydrides (eg calcium hydride) and metal alkoxides (eg sodium t-butoxy, potassium t-butoxy). do.
  • the said base can be used individually by 1 type or in combination of 2 or more types.
  • the reaction in step A is preferably carried out in a solvent.
  • Suitable examples of the solvent include halogen solvents (eg, dichloromethane, chloroform, dichloroethane), alcohol solvents (eg, ethanol, propanol, butanol, t-amyl alcohol, pentanol), and nitrile solvents (eg, acetonitrile). ).
  • the said solvent can be used individually by 1 type or in combination of 2 or more types.
  • the reaction temperature in step A is not particularly limited as long as the reaction proceeds.
  • the lower limit of the reaction temperature can be, for example, 5°C, 10°C, or 15°C.
  • the upper limit of the reaction temperature can be, for example, 100°C, 90°C, or 80°C.
  • the reaction temperature can be, for example, 5-100°C, 10-90°C, or 15-80°C.
  • the method for producing the compound represented by formula (1) or a salt thereof may further include step B of deprotecting the hydroxyl-protecting group.
  • Deprotection in step B can be carried out according to a conventional method.
  • the compound represented by formula (1) or a method for producing the same comprises Step D, carried out in the same manner as Step A, except that 2-amino-6-chloro-9H-proline is used in place of the compound represented by formula (3);
  • the product obtained from step D is reacted (Sandmeyer reaction ) with nitrite or nitrite ester and a bromine source (e.g. CuBr, CH2Br2 ) or an iodine source (e.g. CuI, CH2I2 ).
  • the compound represented by formula (1) or the method for producing the same may include step G of reacting the deprotected product obtained in step B or step F with R 3 COOH or its ester or halide.
  • the reaction of step G (esterification reaction) can be carried out according to a conventional method.
  • the product obtained in each step may be purified by means of filtration, column chromatography, concentration, extraction, etc., if desired.
  • the content of the compound represented by formula (1) or a salt thereof in the pest control composition is preferably an effective amount for controlling pests.
  • the lower limit of the content is, for example, 0.01 parts by mass, 0.05 parts by mass, 0.1 parts by mass, 0.5 parts by mass, 1 part by mass, and 5 parts by mass with respect to 100 parts by mass of the pest control composition. parts, or 10 parts by weight.
  • the upper limit of the content is, for example, 99 parts by mass, 90 parts by mass, 85 parts by mass, 80 parts by mass, 75 parts by mass, 70 parts by mass, 65 parts by mass, 60 parts by mass with respect to 100 parts by mass of the pest control composition. parts, 55 parts by weight, or 50 parts by weight.
  • the content can be, for example, 0.01 to 99 parts by mass, 0.05 to 90 parts by mass, or 0.1 to 80 parts by mass with respect to 100 parts by mass of the pest control composition.
  • the pest control composition preferably contains the compound represented by formula (1) or a salt thereof, and a carrier.
  • the carrier may be a solid carrier, a liquid carrier, or a gaseous carrier.
  • solid carriers include inorganic particles such as activated carbon, silica, talc, titanium dioxide, zeolite, calcium carbonate, and calcium phosphate; clay minerals such as kaolin, diatomaceous earth, bentonite, clay, and acid clay; polyethylene, polypropylene, polyvinylidene chloride, and the like. polymer particles; fertilizers; wood flour and the like.
  • inorganic particles such as activated carbon, silica, talc, titanium dioxide, zeolite, calcium carbonate, and calcium phosphate
  • clay minerals such as kaolin, diatomaceous earth, bentonite, clay, and acid clay
  • polyethylene, polypropylene, polyvinylidene chloride, and the like polymer particles
  • fertilizers wood flour and the like.
  • Liquid carriers include, for example, water (e.g. tap water, ion-exchanged water, distilled water, sterilized water), alcohols (e.g. methanol, ethanol, isopropanol, butanol, ethylene glycol, propylene glycol), ethers (e.g. diethyl ether, methyl cellosolve, ethyl cellosolve, dimethyl cellosolve, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, tetrahydrofuran, dioxane), esters (e.g. ethyl acetate, diethyl phthalate), ketones (e.g.
  • aliphatic hydrocarbons e.g. kerosene, mineral oil
  • aromatic hydrocarbons e.g. xylene, toluene, alkylnaphthalene
  • halogenated hydrocarbons e.
  • gaseous carriers examples include butane gas; freon gas; alternative freon gases such as HFO and HFC; liquefied petroleum gas (LPG);
  • the carriers can be used singly or in combination of two or more.
  • the carrier is a solid carrier or a liquid carrier.
  • the lower limit of the ratio (mass ratio) of the content of the carrier to the content of the compound represented by formula (1) or a salt thereof can be 0.1, 0.5, or 1, for example.
  • the upper limit of the ratio can be 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, or 10, for example.
  • the ratio can be, for example, 0.1-1000, 0.5-500, or 1-100.
  • the pest control composition can further contain optional additional ingredients (or adjuvants).
  • additional ingredients is a surfactant.
  • Surfactants may be any of nonionic surfactants, anionic surfactants, cationic surfactants, and amphoteric surfactants.
  • nonionic surfactants include fatty acid dialkanolamides (e.g. lauric acid diethanolamide), polyoxyalkylene fatty acid amides (e.g. polyoxyethylene stearamide), polyoxyalkylene aryl ethers (e.g. polyoxyethylene phenyl ether), polyoxyalkylene alkyl aryl ethers (e.g. polyoxyethylene octylphenyl ether), polyoxyalkylene alkyl or alkenyl ethers (e.g.
  • polyoxyethylene lauryl ether polyoxyethylene stearyl ether
  • fatty acid esters of polyhydric alcohols Example: polyethylene glycol mono- or distearate, polyethylene glycol mono- or dilaurate, polyoxyethylene hydrogenated castor oil
  • glycerin fatty acid ester eg: glyceryl monostearate, glyceryl monooleate
  • sorbitan fatty acid ester eg: sorbitan monolaurate, sorbitan monostearate
  • polyoxyethylene-polyoxypropylene block polymers and the like.
  • anionic surfactants include alkanesulfonic acid (e.g. dodecanesulfonic acid), arenesulfonic acid (e.g. dodecylbenzenesulfonic acid), polyalkylene glycol sulfonic acid (e.g.
  • polyethylene glycol sulfonic acid alkyl sulfate ( lauryl sulfate), polyoxyalkylene alkyl ether sulfate (eg, polyoxyethylene lauryl ether sulfate), polyoxyalkylene alkyl aryl ether sulfate (eg, polyoxyethylene alkylphenyl ether sulfate), alkyl phosphate (eg, lauryl phosphorus acid), polyoxyalkylene alkyl ether phosphate (e.g. polyoxyethylene lauryl ether phosphate), polyoxyalkylene aryl ether phosphate (e.g.
  • polyoxyethylene phenyl ether phosphate or salts thereof (such as sodium salts alkali metal salts), and long-chain fatty acid salts (eg, calcium stearate, magnesium stearate, aluminum monostearate, triethanolamine stearate, triethanolamine oleate), and the like.
  • salts thereof such as sodium salts alkali metal salts
  • long-chain fatty acid salts eg, calcium stearate, magnesium stearate, aluminum monostearate, triethanolamine stearate, triethanolamine oleate
  • cationic surfactants examples include tetraalkylammonium salts (eg, lauryltrimethylammonium chloride, dilauryldimethylammonium chloride), trialkylammonium salts (eg, lauryldimethylbenzylammonium chloride, benzalkonium chloride), tri( polyoxyalkylenealkyl)ammonium salts (eg, tri(polyoxyethylenestearyl)ammonium chloride) and the like.
  • tetraalkylammonium salts eg, lauryltrimethylammonium chloride, dilauryldimethylammonium chloride
  • trialkylammonium salts eg, lauryldimethylbenzylammonium chloride, benzalkonium chloride
  • tri( polyoxyalkylenealkyl)ammonium salts eg, tri(polyoxyethylenestearyl)ammonium chloride
  • amphoteric surfactants include betaines (eg, betaine; alkylbetaines such as dimethyldodecylcarboxybetaine), phosphatidic acid derivatives (eg, lecithin, lysolecithin, phosphatidylethanolamine), dimethylalkylamine oxides, and the like.
  • betaines eg, betaine; alkylbetaines such as dimethyldodecylcarboxybetaine
  • phosphatidic acid derivatives eg, lecithin, lysolecithin, phosphatidylethanolamine
  • dimethylalkylamine oxides and the like.
  • the surfactants can be used singly or in combination of two or more.
  • the lower limit of the ratio (mass ratio) of the content of the surfactant to the content of the compound represented by formula (1) or a salt thereof can be 0.1, 0.5, or 1, for example.
  • the upper limit of the ratio can be 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, or 10, for example.
  • the ratio can be, for example, 0.1-1000, 0.5-500, or 1-100.
  • additional ingredients include antifreeze agents, antifoaming agents, preservatives, antioxidants, thickeners, colorants, plasticizers, lubricants, dispersants, buffers, and trace elements.
  • the pest control composition is, for example, powders [e.g., powders containing 0.1 to 10% by mass of the compound represented by formula (1) or a salt thereof and 90 to 99.9% by mass of a solid carrier], granules [e.g. granules containing 0.1 to 30% by mass of the compound represented by formula (1) or a salt thereof and 70 to 99.5% by mass of solid carrier], Wettable powder [e.g., a hydrating agent containing 0.5 to 90% by mass of a compound represented by formula (1) or a salt thereof, 5 to 95% by mass of a solid carrier, and 0.5 to 20% by mass of a surfactant agent], Suspension concentrate [Example: Suspension concentrate containing 5 to 75% by mass of the compound represented by formula (1) or a salt thereof, 24 to 94% by mass of liquid carrier, and 1 to 40% by mass of surfactant product], or an emulsifiable concentrate [e.g., a suspension containing 1 to 95% by mass of a compound represented
  • the pests that can be controlled by the pest control composition can be, for example, pests or pathogens, and are preferably pests or pathogens for plants.
  • pests include, but are not limited to, insects, nematodes, mites, and ticks.
  • the pests are preferably pests belonging to the systems or classifications shown in the table below.
  • the pest is more preferably a lepidopteran pest or a hemiptera pest, even more preferably a lepidopteran pest, and is at least one selected from the group consisting of diamondback moth pests and noctuid pests. Especially preferred.
  • pathogens examples include rice blast pathogens, crest pathogens, anthrax pathogens, plague pathogens, powdery mildew pathogens, brown spot pathogens, mold pathogens (e.g. gray mold pathogens), rust pathogens, black star pathogens, brown streak pathogens, and banae.
  • Pathogens seedling wilt pathogens, rice rot pathogens, soft rot pathogens, canker pathogens, black rot pathogens, rot pathogens, flower thunder rot pathogens, root-knot pathogens, bacterial wilt pathogens, root rot pathogens, vine split pathogens, yellowing wilt pathogens , leaf blight pathogen, smut pathogen, and the like, but are not limited to these.
  • the pathogen is preferably at least one selected from the group consisting of rice blast pathogen, sheath blight pathogen, anthrax pathogen, and brown spot pathogen.
  • the plant When the pest controllable by the pest control composition is a plant pest or pathogen, the plant may be a whole plant or a part of the plant. Examples of plant parts include stems, leaves, flowers, ears, fruits, stems, branches, seeds, roots, shoots, and seedlings.
  • plants examples include gramineous plants (e.g., rice, barley, wheat, corn, oats), cruciferous plants (e.g., Japanese radish, turnip, Chinese cabbage, cabbage, white mustard, mizuna, mibuna, Japanese mustard spinach, broccoli, cauliflower), Cucurbitaceous plants (e.g. pumpkin, cucumber, white mustard, watermelon, castor bean, melon), solanaceous plants (e.g. peppers, eggplants, tomatoes, peppers, potatoes, green peppers), umbelliferous plants (e.g. carrots, parsley, mitsuba, celery), Liliaceae plants (e.g.
  • gramineous plants e.g., rice, barley, wheat, corn, oats
  • cruciferous plants e.g., Japanese radish, turnip, Chinese cabbage, cabbage, white mustard, mizuna, mibuna, Japanese mustard spinach, broccoli, cauliflower
  • Cucurbitaceous plants e.g. pumpkin, cucumber, white mustard
  • Asteraceae plants e.g. chrysanthemums, chrysanthemums, burdocks, sunflowers, lettuce, butterbur, baby leaves
  • Chenopodiaceae plants e.g. spinach, Swiss chard
  • bindweed e.g. sweet potato
  • legumes e.g. peas, soybeans, fava beans, edamame, kidney beans, peanuts
  • roses e.g. strawberries, peaches, plums, apples, pears
  • grapes Includes family plants (eg grapes).
  • the plant is preferably at least one selected from the group consisting of gramineous plants, cruciferous plants, cucurbitaceous plants, leguminous plants, rosaceous plants, and vine plants. , cucurbitaceous plants, and legumes.
  • the pest control composition may be applied directly to the pest, or applied to a place where the pest lives or can live (or generate).
  • places where harmful organisms live or can live include places where agricultural products and foliage plants are grown (e.g. vinyl greenhouses, orchards, fields, gardens, planters), places where agricultural products and foliage plants are stored ( Examples: kitchens, warehouses), etc.
  • the pest control composition may be applied directly to the plant (in whole or in part) or to the soil in which the plant is grown.
  • all the methods generally employed for application of pest control compositions can be employed, for example, application or spraying.
  • the lower limit of the application amount of the pest control composition is, for example, 1 g, 5 g, 10 g, 15 g, 20 g, 25 g, 30 g, 35 g, 40 g, 45 g, 50 g, 100 g, 200 g, 300 g, 400 g, or 500 g per hectare of application area.
  • the upper limit of the application amount can be, for example, 10,000 g, 9,000 g, 8,000 g, 7,000 g, 6,000 g, 5,000 g, 4,000 g, 3,000 g, and 2,000 g per ha.
  • the application rate can be, for example, 1-10000 g, 5-9000 g, or 10-8000 g per ha.
  • the compound represented by formula (1a) or a salt thereof in the present disclosure is represented by the following formula (1a):
  • R 1a and R 2a are each independently a hydrocarbon group optionally having one or more substituents, R 3a CO—, or a sulfamoyl group, R 3a is a hydrocarbon group optionally having one or more substituents, X a is a halogen, a nitro group, a cyano group, a hydrocarbon group optionally having one or more substituents, a heteroaryl group, R 4a O—, or R 5a S—; R 4a and R 5a are each hydrogen or a hydrocarbon group optionally having one or more substituents, Z a is a halogen, an azide group, a cyano group, or R 8a O—; R 8a is a hydrocarbon group optionally having one or more substituents.
  • the compound represented by or its salt is included.
  • R 1a and R 2a are each independently a hydrocarbon group optionally having one or more substituents, or R 3a CO—, preferably one or more substituted an alkyl group optionally having a group, an aryl group optionally having one or more substituents, an aralkyl group optionally having one or more substituents, or R 3a CO— more preferably an alkyl group optionally having one or more substituents, or R 3a CO—, even more preferably an alkyl group or R 3a CO—, and R 3a CO— is particularly preferred.
  • R 1a and R 2a are preferably the same group.
  • R 3a is an alkyl group optionally having one or more substituents, an aryl group optionally having one or more substituents, or It is preferably an aralkyl group that may have one or more substituents, more preferably an alkyl group that may have one or more substituents, or an aryl group that may have one or more substituents.
  • An alkyl group which may have one or more substituents is preferred, and more preferred.
  • the substituent is preferably a hydroxyl group, a mercapto group, an alkoxy group, or an alkylthio group, more preferably an alkoxy group or an alkylthio group, and even more preferably an alkoxy group.
  • the number of the substituents may be one or more and not more than the maximum substitutable number, preferably one or two.
  • X a is a halogen, nitro group, cyano group, alkyl group, alkenyl group, alkynyl group, cycloalkyl group, aryl group, heteroaryl group, R 4a O—, or R 5a S— is preferred, halogen, a cyano group, or R 4a O— is more preferred, halogen is even more preferred, and fluorine, chlorine, or bromine is even more preferred.
  • R 4a and R 5a are each hydrogen, an alkyl group optionally having one or more substituents, an aryl group optionally having one or more substituents, or 1 It is preferably an aralkyl group optionally having one or more substituents, such as hydrogen, an alkyl group optionally having one or more substituents, or having one or more substituents It is more preferably an aryl group that may be substituted, more preferably hydrogen or an alkyl group optionally having one or more substituents, and even more preferably hydrogen or an alkyl group.
  • Z a is preferably halogen, more preferably fluorine.
  • R 8a is an alkyl group optionally having one or more substituents, an aryl group optionally having one or more substituents, or It is preferably an aralkyl group that may have one or more substituents, more preferably an alkyl group that may have one or more substituents, or an aryl group that may have one or more substituents.
  • An alkyl group optionally having one or more substituents is preferred, and an alkyl group is even more preferred.
  • R 1a and R 2a are each independently R 3a CO—, and R 3a is an alkyl group optionally having one or more substituents (eg, an alkoxy group). and X a and Z a are each independently preferably halogen, R 1a and R 2a are each independently R 3a CO—, and R 3a is one or more substituents It is an alkyl group optionally having (eg, an alkoxy group), X a is fluorine, and Z a is more preferably halogen.
  • the compound represented by formula (1a) or a salt thereof is preferably a compound or a salt thereof selected from the group consisting of the following formulas (1a-1) to (1a-9).
  • the salt of the compound represented by formula (1a) can be, for example, a salt with an acid or base exemplified for the salt of the compound represented by formula (1).
  • the compound represented by formula (1a) or a salt thereof can be produced, for example, in the same manner as the compound represented by formula (1) or a salt thereof.
  • Example 1 After dissolving 5 g (10.8 mmol) of 2-deoxy-2-fluoro-1,3,5-tri-O-benzoyl- ⁇ -D-arabinofuranose in 20 mL of dehydrated dichloromethane, hydrogen bromide-acetic acid solution (5.1 mol /L) 4.8 mL (24.5 mmol) was added dropwise and stirred for 16 hours. After adding chloroform to the reaction solution, the reaction solution was washed with water, a saturated aqueous solution of sodium hydrogencarbonate and saturated brine in that order, and dried by adding sodium sulfate. After filtering this solution, 4.56g of compounds 1 were obtained by concentration-drying.
  • Example 2 After 0.122 g (0.4 mmol) of compound 3 was dissolved in 3.0 mL of dehydrated pyridine, 0.127 mL (0.922 mmol) of 4-methylpentanoyl chloride was added and stirred for 16 hours. Chloroform and 3N HCl were added to the reaction solution for liquid separation, and the mixture was washed with water. After concentrating and drying this chloroform layer, 0.145g of compound 4 was obtained by performing column refinement
  • Example 3 After 0.122 g (0.4 mmol) of compound 3 was dissolved in 3.0 mL of dehydrated pyridine, 0.084 mL (0.92 mmol) of methoxyacetyl chloride was added and stirred for 16 hours. Chloroform and 3N HCl were added to the reaction solution for liquid separation, and the mixture was washed with water. After concentrating and drying this chloroform layer, 0.123g of compound 5 was obtained by performing column refinement
  • Example 4 After 0.139 g (0.46 mmol) of compound 3 was dissolved in 5.0 mL of dehydrated pyridine, 0.146 mL (1.05 mmol) of hexanoyl chloride was added and stirred for 16 hours. Chloroform and 3N HCl were added to the reaction solution for liquid separation, and the mixture was washed with water. After concentrating and drying this chloroform layer, 0.12g of compound 6 was obtained by performing column refinement
  • Example 6 After 0.121 g (0.348 mmol) of compound 7 was dissolved in 5.0 mL of dehydrated pyridine, 0.105 mL (0.767 mmol) of 4-methylpentanoyl chloride was added and stirred for 16 hours. Ethyl acetate and 3N HCl were added to the reaction solution for liquid separation, and then washed with water. After concentrating and drying this ethyl acetate layer, 0.195g of compound 8 was obtained by performing column refinement
  • Example 7 After 0.08 g (0.23 mmol) of compound 7 was dissolved in 8.0 mL of dehydrated pyridine, 0.0694 mL (0.506 mmol) of hexanoyl chloride was added and stirred for 16 hours. After the reaction solution was concentrated to dryness, 0.061 g of compound 9 was obtained by performing column purification.
  • Example 8 After 0.16 g (0.46 mmol) of compound 7 was dissolved in 4.0 mL of dehydrated pyridine, 0.092 mL (1.01 mmol) of methoxyacetyl chloride was added and stirred for 16 hours. Chloroform and 3N HCl were added to the reaction solution, and the mixture was separated and then washed with water. After concentrating and drying this chloroform layer, 0.11g of compound 10 was obtained by performing column refinement
  • Example 9 After dissolving 1.26 g (2.98 mmol) of compound 1 and 1.10 g (7.18 mmol) of 2-fluoroadenine in 10 mL of dehydrated acetonitrile, 2.76 mL (8.96 mmol) of BSA was added and the mixture was stirred at 80°C for 1 hour. After cooling to 0°C, 1.3 mL (7.18 mmol) of trimethylsilyl trifluoromethanesulfonate was added, and the mixture was stirred for 15 minutes, then heated to 80°C again and stirred overnight. A saturated aqueous sodium hydrogencarbonate solution and chloroform were added to the reaction solution, and the mixture was filtered through celite and separated. This chloroform layer was washed with water, concentrated to dryness, and subjected to column purification to obtain 0.254 g of compound 11.
  • Example 11 After 0.102 g (0.355 mmol) of compound 12 was dissolved in 3.0 mL of dehydrated pyridine, 0.112 mL (0.817 mmol) of 4-methylpentanoyl chloride was added and stirred for 16 hours. Chloroform and 3N HCl were added to the reaction solution for liquid separation, and the mixture was washed with water. After concentrating and drying this chloroform layer, 0.129g of compound 14 was obtained by performing column refinement
  • An emulsion was prepared.
  • a diluted solution of a predetermined concentration was prepared with water containing 10,000 times the spreading agent Grameen S (Toyo Green Co., Ltd.). A sufficient amount of the diluted drug solution was sprayed on each sample with a spray gun.
  • An emulsion was prepared.
  • a diluted solution of a predetermined concentration was prepared with water containing 10,000 times the spreading agent Grameen S (Toyo Green Co., Ltd.). A sufficient amount of the diluted drug solution was sprayed on the sample with a spray gun.
  • Test method for sheath blight fungi Spray the chemical on rice at the 5-leaf stage, sprinkle the sheath blight fungus (winter) on the ground, leave it in a wet room for 6 days, measure the increase in lesions, and control. The value was calculated based on the above formula (N).
  • Test method for anthracnose fungus Primary leaves of soybean at the stage of full development of the first true leaf were sprayed with a chemical agent, inoculated with a spore suspension of anthracnose fungus by spraying, and left in a moist room for 7 days. The lesion area on the leaves was measured, and the control value was calculated based on the above formula (N).
  • Test method for Pseudomonas aeruginosa Two-leaf stage cucumbers were sprayed with the drug, spray-inoculated with a spore suspension of Pseudomonas aeruginosa, and left in a wet room for 8 days. The lesion area on the leaves was measured, and the control value was calculated based on the above formula (N).

Abstract

The present invention addresses the problem of providing a composition useful for controlling pests. Disclosed is a pest controlling composition comprising a compound represented by formula (1) (in the formula: R1 and R2 independently represent hydrogen, a hydrocarbon group optionally having one or more substituents, R3CO- or a sulfamoyl group, wherein R3 represents a hydrocarbon group optionally having one or more substituents; X represents hydrogen, a halogen, a nitro group, a cyano group, a hydrocarbon group optionally having one or more substituents, a heteroaryl group, R4O-, R5S- or R6R7N-, wherein R4, R5, R6 and R7 independently represent hydrogen or a hydrocarbon group optionally having one or more substituents; and Z represents hydrogen, a halogen, an azide group, a cyano group or R8O-, wherein R8 represents a hydrocarbon group optionally having one or more substituents) or a salt thereof.

Description

有害生物防除組成物pest control composition
 本開示は、主に有害生物防除組成物に関する。 The present disclosure primarily relates to pest control compositions.
 クロファラビンは、核酸アナログ代謝拮抗薬に分類される第2世代のプリン拮抗薬である。クロファラビンは、細胞内の酵素によって活性型のクロファラビン三リン酸に変換され、リボヌクレオチド還元酵素及びDNAポリメラーゼαの両方の酵素を阻害することにより、白血病細胞でのDNA合成や修復を阻害し、細胞死を誘導する。クロファラビンを有効成分とするエボルトラ(商標)点滴静注20mgが開発され、「再発又は難治性の急性リンパ性白血病」を効能効果として、製造販売が承認されている(非特許文献1)。 Clofarabine is a second-generation purine antagonist classified as a nucleic acid analog antimetabolite. Clofarabine is converted to active clofarabine triphosphate by intracellular enzymes, and by inhibiting both ribonucleotide reductase and DNA polymerase α, it inhibits DNA synthesis and repair in leukemia cells. induce death. Evoltra (trademark) intravenous infusion 20 mg containing clofarabine as an active ingredient has been developed, and its manufacture and sale has been approved for its efficacy in treating "relapsed or refractory acute lymphocytic leukemia" (Non-Patent Document 1).
 本開示は、有害生物防除に有用な組成物を提供することを1つの課題とする。 An object of the present disclosure is to provide a composition useful for controlling pests.
 本開示は、次の態様を含む。
項1.
 下記式(1):
Figure JPOXMLDOC01-appb-C000003
(式中、
及びRは、それぞれ独立して、水素、1個以上の置換基を有していてもよい炭化水素基、RCO-、又はスルファモイル基であり、
は、1個以上の置換基を有していてもよい炭化水素基であり、
Xは、水素、ハロゲン、ニトロ基、シアノ基、1個以上の置換基を有していてもよい炭化水素基、ヘテロアリール基、RO-、RS-、又はRN-であり、
、R、R、及びRは、それぞれ独立して、水素、又は1個以上の置換基を有していてもよい炭化水素基であり、
Zは、水素、ハロゲン、アジド基、シアノ基、又はRO-であり、
は、1個以上の置換基を有していてもよい炭化水素基である。)
で表される化合物又はその塩を含有する有害生物防除組成物。
項2.
 R及びRが、それぞれ独立して、水素、又はRCO-である、項1に記載の有害生物防除組成物。
項3.
 Rが、1個以上の置換基を有していてもよいアルキル基である、項1又は2に記載の有害生物防除組成物。
項4.
 Xが、水素、ハロゲン、ニトロ基、シアノ基、アルキル基、アルケニル基、アルキニル基、シクロアルキル基、アリール基、ヘテロアリール基、RO-、RS-、又はRN-であり、
、R、R、及びRが、それぞれ独立して、水素、又は1個以上の置換基を有していてもよいアルキル基である、
項1~3のいずれか一項に記載の有害生物防除組成物。
項5.
 Xが、ハロゲン、シアノ基、又はRO-である、項1~4のいずれか一項に記載の有害生物防除組成物。
項6.
 Xが、フッ素、塩素、又は臭素である、項1~5のいずれか一項に記載の有害生物防除組成物。
項7.
 Zが、ハロゲンである、項1~6のいずれか一項に記載の有害生物防除組成物。
項8.
 Zが、フッ素である、項1~7のいずれか一項に記載の有害生物防除組成物。
項9.
 前記有害生物が、植物に対する病害虫又は病原菌である、項1~8のいずれか一項に記載の有害生物防除組成物。
項10.
 前記植物が、イネ科植物、アブラナ科植物、ウリ科植物、マメ科植物、バラ科植物、及びブドウ科植物からなる群より選択される少なくとも一種である、項9に記載の有害生物防除組成物。
項11.
 前記有害生物が、鱗翅目害虫、半翅目害虫、いもち病原菌、紋枯病原菌、炭疽病原菌、及び褐斑病原菌からなる群より選択される少なくとも一種である、項1~10のいずれか一項に記載の有害生物防除組成物。
項12.
 植物に直接施用する、又は植物を栽培する土壌に施用するための、項1~11のいずれか一項に記載の有害生物防除組成物。
項13.
 下記式(1a):
Figure JPOXMLDOC01-appb-C000004
(式中、
1a及びR2aは、それぞれ独立して、1個以上の置換基を有していてもよい炭化水素基、R3aCO-、又はスルファモイル基であり、
3aは、1個以上の置換基を有していてもよい炭化水素基であり、
は、ハロゲン、ニトロ基、シアノ基、1個以上の置換基を有していてもよい炭化水素基、ヘテロアリール基、R4aO-、又はR5aS-であり、
4a及びR5aは、それぞれ、水素、又は1個以上の置換基を有していてもよい炭化水素基であり、
は、ハロゲン、アジド基、シアノ基、又はR8aO-であり、
8aは、1個以上の置換基を有していてもよい炭化水素基である。)
で表される化合物又はその塩。
The present disclosure includes the following aspects.
Section 1.
Formula (1) below:
Figure JPOXMLDOC01-appb-C000003
(In the formula,
R 1 and R 2 are each independently hydrogen, a hydrocarbon group optionally having one or more substituents, R 3 CO—, or a sulfamoyl group;
R 3 is a hydrocarbon group optionally having one or more substituents,
X is hydrogen, halogen, nitro group, cyano group, hydrocarbon group optionally having one or more substituents, heteroaryl group, R 4 O—, R 5 S—, or R 6 R 7 N - and
R 4 , R 5 , R 6 and R 7 are each independently hydrogen or a hydrocarbon group optionally having one or more substituents,
Z is hydrogen, halogen, an azide group, a cyano group, or R 8 O—;
R 8 is a hydrocarbon group optionally having one or more substituents. )
A pest control composition containing a compound represented by or a salt thereof.
Section 2.
Item 2. The pest control composition according to Item 1, wherein R 1 and R 2 are each independently hydrogen or R 3 CO-.
Item 3.
Item 3. The pest control composition according to Item 1 or 2, wherein R3 is an alkyl group optionally having one or more substituents.
Section 4.
X is hydrogen, halogen, nitro group, cyano group, alkyl group, alkenyl group, alkynyl group, cycloalkyl group, aryl group, heteroaryl group, R 4 O—, R 5 S—, or R 6 R 7 N— and
R 4 , R 5 , R 6 and R 7 are each independently hydrogen or an alkyl group optionally having one or more substituents;
Item 4. The pest control composition according to any one of items 1 to 3.
Item 5.
Item 5. The pest control composition according to any one of Items 1 to 4, wherein X is a halogen, a cyano group, or R 4 O-.
Item 6.
Item 6. The pest control composition according to any one of Items 1 to 5, wherein X is fluorine, chlorine, or bromine.
Item 7.
Item 7. The pest control composition according to any one of Items 1 to 6, wherein Z is a halogen.
Item 8.
Item 8. The pest control composition according to any one of Items 1 to 7, wherein Z is fluorine.
Item 9.
Item 9. The pest control composition according to any one of items 1 to 8, wherein the pest is a plant pest or pathogen.
Item 10.
Item 10. The pest control composition according to Item 9, wherein the plant is at least one selected from the group consisting of gramineous plants, cruciferous plants, cucurbitaceous plants, leguminous plants, rosaceous plants, and vine plants. .
Item 11.
Item 11. The pest according to any one of Items 1 to 10, wherein the pest is at least one selected from the group consisting of lepidopteran pests, hemiptera pests, rice blast pathogens, sheath blight pathogens, anthrax pathogens, and brown spot pathogens. A pest control composition as described.
Item 12.
Item 12. The pest control composition according to any one of items 1 to 11, which is applied directly to plants or applied to soil in which plants are grown.
Item 13.
Formula (1a) below:
Figure JPOXMLDOC01-appb-C000004
(In the formula,
R 1a and R 2a are each independently a hydrocarbon group optionally having one or more substituents, R 3a CO—, or a sulfamoyl group,
R 3a is a hydrocarbon group optionally having one or more substituents,
X a is a halogen, a nitro group, a cyano group, a hydrocarbon group optionally having one or more substituents, a heteroaryl group, R 4a O—, or R 5a S—;
R 4a and R 5a are each hydrogen or a hydrocarbon group optionally having one or more substituents,
Z a is a halogen, an azide group, a cyano group, or R 8a O—;
R 8a is a hydrocarbon group optionally having one or more substituents. )
A compound represented by or a salt thereof.
 本開示によれば、例えば有害生物防除に有用な組成物が提供される。 According to the present disclosure, compositions useful for controlling pests, for example, are provided.
 本開示の前記概要は、本開示の各々の開示された実施形態又は全ての実装を記述することを意図するものではない。本開示の後記説明は、実例の実施形態をより具体的に例示する。 The above summary of the present disclosure is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The ensuing description of this disclosure more particularly exemplifies illustrative embodiments.
 本開示のいくつかの箇所では、例示を通してガイダンスが提供され、及びこの例示は、様々な組み合わせにおいて使用できる。それぞれの場合において、例示の群は、非排他的な、及び代表的な群として機能できる。 In several places of this disclosure, guidance is provided through examples, and the examples can be used in various combinations. In each case, the exemplary group can serve as a non-exclusive and representative group.
 本明細書で引用した全ての刊行物、特許及び特許出願はそのまま引用により本明細書に組み入れられる。 All publications, patents and patent applications cited herein are hereby incorporated by reference as is.
1.用語
 本明細書中の記号及び略号は、特に限定のない限り、本明細書の文脈に沿い、本開示が属する技術分野において通常用いられる意味に理解できる。
1. Terms The symbols and abbreviations used in the present specification can be understood to have meanings commonly used in the technical field to which the present disclosure belongs, in accordance with the context of the present specification, unless otherwise specified.
 本明細書中、語句「含有する」は、語句「から本質的になる」、及び語句「からなる」を包含することを意図して用いられる。 In this specification, the phrase "contains" is intended to include the phrase "consisting essentially of" and the phrase "consisting of".
 特に限定されない限り、本明細書中に記載されている工程、処理、又は操作は、室温で実施され得る。本明細書中、室温は、10~40℃の範囲内の温度を意味することができる。 Unless otherwise specified, the steps, treatments, or operations described herein may be performed at room temperature. Herein room temperature can mean a temperature within the range of 10-40°C.
 本明細書中、表記「Cn-m」(ここで、n、及びmは、それぞれ、正の整数であり、n<mである。)は、当業者が通常理解する通り、炭素数がn以上、且つm以下であることを表す。 In this specification, the notation “C nm ” (where n and m are each positive integers and n<m) means that the number of carbon atoms is It represents n or more and m or less.
 本明細書中、「炭化水素基」は、炭素及び水素のみからなる基を意味する。「炭化水素基」の例は、(1)1個以上の芳香族炭化水素基(アリール基)で置換されていてもよい脂肪族炭化水素基、及び(2)1個以上の脂肪族炭化水素基で置換されていてもよい芳香族炭化水素基を包含する。 As used herein, the term "hydrocarbon group" means a group consisting only of carbon and hydrogen. Examples of the "hydrocarbon group" include (1) an aliphatic hydrocarbon group optionally substituted with one or more aromatic hydrocarbon groups (aryl groups), and (2) one or more aliphatic hydrocarbon Aromatic hydrocarbon groups optionally substituted with groups are included.
 「炭化水素基」は、直鎖状、分岐鎖状、環状、又はそれらの組み合わせである構造を有することができる。 A "hydrocarbon group" can have a structure that is linear, branched, cyclic, or a combination thereof.
 本明細書中、「脂肪族炭化水素基」は、飽和又は不飽和であることができる。「脂肪族炭化水素基」の例は、アルキル基、アルケニル基、アルキニル基、シクロアルキル基、及びシクロアルケニル基を包含する。 As used herein, the "aliphatic hydrocarbon group" can be saturated or unsaturated. Examples of "aliphatic hydrocarbon groups" include alkyl groups, alkenyl groups, alkynyl groups, cycloalkyl groups, and cycloalkenyl groups.
 本明細書中、「アルキル基」の例は、直鎖状又は分岐鎖状のC1-12アルキル基を包含し、及びその具体例は、メチル基、エチル基、プロピル基(例:n-プロピル基、イソプロピル基)、ブチル基(例:n-ブチル基、イソブチル基、sec-ブチル基、tert-ブチル基)、ペンチル基(例:n-ペンチル基、tert-ペンチル基、ネオペンチル基、イソペンチル基、sec-ペンチル基、3-ペンチル基)、ヘキシル基、ヘプチル基、オクチル基、ノニル基、及びデシル基を包含する。 As used herein, examples of the "alkyl group" include linear or branched C 1-12 alkyl groups, and specific examples thereof include methyl, ethyl, and propyl groups (eg, n- propyl group, isopropyl group), butyl group (eg n-butyl group, isobutyl group, sec-butyl group, tert-butyl group), pentyl group (eg n-pentyl group, tert-pentyl group, neopentyl group, isopentyl group, sec-pentyl group, 3-pentyl group), hexyl group, heptyl group, octyl group, nonyl group, and decyl group.
 本明細書中、「アルケニル基」の例は、直鎖状又は分岐鎖状のC2-10アルケニル基を包含し、及びその具体例は、ビニル基、1-プロペニル基、イソプロペニル基、2-メチル-1-プロペニル基、1-ブテニル基、2-ブテニル基、3-ブテニル基、2-エチル-1-ブテニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、4-メチル-3-ペンテニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、及び5-ヘキセニル基を包含する。 As used herein, examples of “alkenyl group” include linear or branched C 2-10 alkenyl groups, and specific examples thereof include vinyl, 1-propenyl, isopropenyl, 2 -methyl-1-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 2-ethyl-1-butenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl 4-methyl-3-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, and 5-hexenyl groups.
 本明細書中、「アルキニル基」の例は、直鎖状又は分岐鎖状のC2-10アルキニル基を包含し、及びその具体例は、エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-ペンチニル基、2-ペンチニル基、3-ペンチニル基、4-ペンチニル基、1-ヘキシニル基、2-ヘキシニル基、3-ヘキシニル基、4-ヘキシニル基、及び5-ヘキシニル基を包含する。 As used herein, examples of "alkynyl group" include linear or branched C 2-10 alkynyl groups, and specific examples thereof include ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-hexynyl group, 2-hexynyl group, 3-hexynyl group, 4-hexynyl groups and 5-hexynyl groups are included.
 本明細書中、「シクロアルキル基」の例は、C3-10シクロアルキル基を包含し、及びその具体例は、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロヘプチル基、シクロオクチル基、及びアダマンチル基を包含する。 As used herein, examples of “cycloalkyl group” include C 3-10 cycloalkyl groups, and specific examples thereof include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl and adamantyl groups.
 本明細書中、「シクロアルケニル基」の例は、C3-10シクロアルケニル基を包含し、及びその具体例は、シクロプロペニル基、シクロブテニル基、シクロペンテニル基、シクロヘキセニル基、及びシクロヘプテニル基を包含する。 As used herein, examples of "cycloalkenyl groups" include C 3-10 cycloalkenyl groups, and specific examples thereof include cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl, and cycloheptenyl groups. contain.
 本明細書中、「芳香族炭化水素基(アリール基)」は、例えば単環性、2環性、3環性、又は4環性であることができる。「芳香族炭化水素基」の例は、C6-14芳香族炭化水素基を包含し、及びその具体例は、フェニル基、1-ナフチル基、2-ナフチル基、2-ビフェニル基、3-ビフェニル基、4-ビフェニル基、及び2-アンスリル基を包含する。 As used herein, an "aromatic hydrocarbon group (aryl group)" can be, for example, monocyclic, bicyclic, tricyclic, or tetracyclic. Examples of “aromatic hydrocarbon group” include C 6-14 aromatic hydrocarbon groups, and specific examples thereof include phenyl, 1-naphthyl, 2-naphthyl, 2-biphenyl, 3- It includes biphenyl groups, 4-biphenyl groups, and 2-anthryl groups.
 本明細書中、前記芳香族炭化水素基で置換された前記脂肪族炭化水素基の例は、アリールアルキル基(アラルキル基)を包含し、及びその具体例は、ベンジル基、フェネチル基、ジフェニルメチル基、1-ナフチルメチル基、2-ナフチルメチル基、2,2-ジフェニルエチル基、3-フェニルプロピル基、4-フェニルブチル基、5-フェニルペンチル基、2-ビフェニルメチル基、3-ビフェニルメチル基、及び4-ビフェニルメチル基等のC7-15アラルキル基を包含する。 In the present specification, examples of the aliphatic hydrocarbon group substituted with the aromatic hydrocarbon group include arylalkyl groups (aralkyl groups), and specific examples thereof include benzyl group, phenethyl group, diphenylmethyl group, 1-naphthylmethyl group, 2-naphthylmethyl group, 2,2-diphenylethyl group, 3-phenylpropyl group, 4-phenylbutyl group, 5-phenylpentyl group, 2-biphenylmethyl group, 3-biphenylmethyl and C 7-15 aralkyl groups such as the 4-biphenylmethyl group.
 本明細書中、炭化水素基に置換し得る置換基の例は、ハロゲン、ヒドロキシル基、メルカプト基、アミノ基、アルコキシ基、アルキルチオ基、モノアルキルアミノ基、及びジアルキルアミノ基を包含する。 In this specification, examples of substituents that can be substituted on hydrocarbon groups include halogens, hydroxyl groups, mercapto groups, amino groups, alkoxy groups, alkylthio groups, monoalkylamino groups, and dialkylamino groups.
 本明細書中、「ハロゲン」の例は、フッ素、塩素、臭素、及びヨウ素を包含する。 Examples of "halogen" in this specification include fluorine, chlorine, bromine, and iodine.
 本明細書中、「アルコキシ基」は、RO-(式中、Rはアルキル基である。)で表される基であることができる。「アルコキシ基」の例は、直鎖状又は分岐鎖状のC1-12アルコキシ基を包含し、及びその具体例はメトキシ基、エトキシ基、プロポキシ基(例:n-プロポキシ基、イソプロポキシ基)、ブトキシ基、ペンチルオキシ基、及びヘキシルオキシ基を包含する。 As used herein, the "alkoxy group" can be a group represented by RO-- (wherein R is an alkyl group). Examples of "alkoxy group" include linear or branched C 1-12 alkoxy group, and specific examples thereof include methoxy group, ethoxy group, propoxy group (e.g. n-propoxy group, isopropoxy group ), butoxy, pentyloxy, and hexyloxy groups.
 本明細書中、「アルキルチオ基」は、RS-(式中、Rはアルキル基である。)で表される基であることができる。「アルキルチオ基」の例は、直鎖状又は分岐鎖状のC1-12アルキルチオ基を包含し、及びその具体例はメチルチオ基、エチルチオ基、プロピルチオ基(例:n-プロピルチオ基、イソプロピルチオ基)、ブチルチオ基、ペンチルチオ基、及びヘキシルチオ基を包含する。 In the present specification, the "alkylthio group" can be a group represented by RS- (wherein R is an alkyl group). Examples of "alkylthio group" include linear or branched C 1-12 alkylthio groups, and specific examples thereof include methylthio, ethylthio, propylthio (e.g. n-propylthio, isopropylthio ), butylthio, pentylthio, and hexylthio groups.
 本明細書中、「モノアルキルアミノ基」は、R-NH-(式中、Rはアルキル基である。)で表される基であることができる。「モノアルキルアミノ基」の例は、モノ直鎖状又は分岐鎖状C1-12アルキルアミノ基を包含し、及びその具体例は、モノメチルアミノ基、モノエチルアミノ基、モノプロピルアミノ基(例:モノn-プロピルアミノ基、モノイソプロピルアミノ基)、及びモノブチルアミノ基を包含する。 As used herein, a "monoalkylamino group" can be a group represented by R-NH- (wherein R is an alkyl group). Examples of "monoalkylamino group" include monolinear or branched C 1-12 alkylamino groups, and specific examples thereof include monomethylamino group, monoethylamino group, monopropylamino group (e.g. : mono n-propylamino group, monoisopropylamino group), and monobutylamino group.
 本明細書中、「ジアルキルアミノ基」は、RN-(式中、2個のRは、それぞれ独立して、アルキル基である。)で表される基であることができる。「ジアルキルアミノ基」の例は、ジ直鎖状又は分岐鎖状C1-12アルキルアミノ基を包含し、及びその具体例は、ジメチルアミノ基、ジエチルアミノ基、エチルメチルアミノ基、ジプロピルアミノ基(例:ジn-プロピルアミノ基、ジイソプロピルアミノ基)、及びメチルプロピルアミノ基(例:メチルn-プロピルアミノ基、メチルイソプロピルアミノ基)を包含する。 As used herein, a "dialkylamino group" can be a group represented by R 2 N-- (in the formula, each of the two R's is independently an alkyl group). Examples of "dialkylamino group" include dilinear or branched C 1-12 alkylamino groups, and specific examples thereof are dimethylamino group, diethylamino group, ethylmethylamino group, dipropylamino group (eg, di-n-propylamino group, diisopropylamino group) and methylpropylamino group (eg, methyl n-propylamino group, methylisopropylamino group).
 本明細書中、「芳香族複素環基(ヘテロアリール基)」は、例えば単環性、2環性、3環性、又は4環性であることができ、5~18員、5~16員、5~14員、又は5~12員であることができる。「芳香族複素環基」の例は、5又は6員の単環性芳香族複素環基、及び5~18員の芳香族縮合複素環基を包含する。 As used herein, the “aromatic heterocyclic group (heteroaryl group)” can be, for example, monocyclic, bicyclic, tricyclic, or tetracyclic, and has 5 to 18 members, 5 to 16 5-14 membered, or 5-12 membered. Examples of the “aromatic heterocyclic group” include 5- or 6-membered monocyclic aromatic heterocyclic groups and 5- to 18-membered aromatic condensed heterocyclic groups.
 本明細書中、「5又は6員の単環性芳香族複素環基」の例は、ピロリル基(例:1-ピロリル基、2-ピロリル基、3-ピロリル基)、フリル基(例:2-フリル基、3-フリル基)、チエニル基(例:2-チエニル基、3-チエニル基)、ピラゾリル基(例:1-ピラゾリル基、3-ピラゾリル基、4-ピラゾリル基)、イミダゾリル基(例:1-イミダゾリル基、2-イミダゾリル基、4-イミダゾリル基)、イソオキサゾリル基(例:3-イソオキサゾリル基、4-イソオキサゾリル基、5-イソオキサゾリル基)、オキサゾリル基(例:2-オキサゾリル基、4-オキサゾリル基、5-オキサゾリル基)、イソチアゾリル基(例:3-イソチアゾリル基、4-イソチアゾリル基、5-イソチアゾリル基)、チアゾリル基(例:2-チアゾリル基、4-チアゾリル基、5-チアゾリル基)、トリアゾリル基(例:1,2,3-トリアゾール-4-イル基、1,2,4-トリアゾール-3-イル基)、オキサジアゾリル基(例:1,2,4-オキサジアゾール-3-イル基、1,2,4-オキサジアゾール-5-イル基)、チアジアゾリル基(例:1,2,4-チアジアゾール-3-イル基、1,2,4-チアジアゾール-5-イル基)、テトラゾリル基、ピリジル基(例:2-ピリジル基、3-ピリジル基、4-ピリジル基)、ピリダジニル基(例:3-ピリダジニル基、4-ピリダジニル基)、ピリミジニル基(例:2-ピリミジニル基、4-ピリミジニル基、5-ピリミジニル基)、及びピラジニル基を包含する。 In the present specification, examples of the "5- or 6-membered monocyclic aromatic heterocyclic group" include a pyrrolyl group (eg, 1-pyrrolyl group, 2-pyrrolyl group, 3-pyrrolyl group), a furyl group (eg: 2-furyl group, 3-furyl group), thienyl group (e.g. 2-thienyl group, 3-thienyl group), pyrazolyl group (e.g. 1-pyrazolyl group, 3-pyrazolyl group, 4-pyrazolyl group), imidazolyl group (Example: 1-imidazolyl group, 2-imidazolyl group, 4-imidazolyl group), isoxazolyl group (example: 3-isoxazolyl group, 4-isoxazolyl group, 5-isoxazolyl group), oxazolyl group (example: 2-oxazolyl group, 4-oxazolyl group, 5-oxazolyl group), isothiazolyl group (e.g. 3-isothiazolyl group, 4-isothiazolyl group, 5-isothiazolyl group), thiazolyl group (e.g. 2-thiazolyl group, 4-thiazolyl group, 5-thiazolyl group), triazolyl group (e.g. 1,2,3-triazol-4-yl group, 1,2,4-triazol-3-yl group), oxadiazolyl group (e.g. 1,2,4-oxadiazol- 3-yl group, 1,2,4-oxadiazol-5-yl group), thiadiazolyl group (e.g. 1,2,4-thiadiazol-3-yl group, 1,2,4-thiadiazol-5-yl group), tetrazolyl group, pyridyl group (e.g., 2-pyridyl group, 3-pyridyl group, 4-pyridyl group), pyridazinyl group (e.g., 3-pyridazinyl group, 4-pyridazinyl group), pyrimidinyl group (e.g., 2- pyrimidinyl group, 4-pyrimidinyl group, 5-pyrimidinyl group), and pyrazinyl group.
 本明細書中、「5~18員の芳香族縮合複素環基」の例は、イソインドリル基(例:1-イソインドリル基、2-イソインドリル基、3-イソインドリル基、4-イソインドリル基、5-イソインドリル基、6-イソインドリル基、7-イソインドリル基)、インドリル基(例:1-インドリル基、2-インドリル基、3-インドリル基、4-インドリル基、5-インドリル基、6-インドリル基、7-インドリル基)、ベンゾ[b]フラニル基(例:2-ベンゾ[b]フラニル基、3-ベンゾ[b]フラニル基、4-ベンゾ[b]フラニル基、5-ベンゾ[b]フラニル基、6-ベンゾ[b]フラニル基、7-ベンゾ[b]フラニル基)、ベンゾ[c]フラニル基(例:1-ベンゾ[c]フラニル基、4-ベンゾ[c]フラニル基、5-ベンゾ[c]フラニル基)、ベンゾ[b]チエニル基、(例:2-ベンゾ[b]チエニル基、3-ベンゾ[b]チエニル基、4-ベンゾ[b]チエニル基、5-ベンゾ[b]チエニル基、6-ベンゾ[b]チエニル基、7-ベンゾ[b]チエニル基)、ベンゾ[c]チエニル基(例:1-ベンゾ[c]チエニル基、4-ベンゾ[c]チエニル基、5-ベンゾ[c]チエニル基)、インダゾリル基(例:1-インダゾリル基、2-インダゾリル基、3-インダゾリル基、4-インダゾリル基、5-インダゾリル基、6-インダゾリル基、7-インダゾリル基)、ベンゾイミダゾリル基(例:1-ベンゾイミダゾリル基、2-ベンゾイミダゾリル基、4-ベンゾイミダゾリル基、5-ベンゾイミダゾリル基)、1,2-ベンゾイソオキサゾリル基(例:1,2-ベンゾイソオキサゾール-3-イル基、1,2-ベンゾイソオキサゾール-4-イル基、1,2-ベンゾイソオキサゾール-5-イル基、1,2-ベンゾイソオキサゾール-6-イル基、1,2-ベンゾイソオキサゾール-7-イル基)、ベンゾオキサゾリル基(例:2-ベンゾオキサゾリル基、4-ベンゾオキサゾリル基、5-ベンゾオキサゾリル基、6-ベンゾオキサゾリル基、7-ベンゾオキサゾリル基)、1,2-ベンゾイソチアゾリル基(例:1,2-ベンゾイソチアゾール-3-イル基、1,2-ベンゾイソチアゾール-4-イル基、1,2-ベンゾイソチアゾール-5-イル基、1,2-ベンゾイソチアゾール-6-イル基、1,2-ベンゾイソチアゾール-7-イル基)、ベンゾチアゾリル基(例:2-ベンゾチアゾリル基、4-ベンゾチアゾリル基、5-ベンゾチアゾリル基、6-ベンゾチアゾリル基、7-ベンゾチアゾリル基)、イソキノリル基(例:1-イソキノリル基、3-イソキノリル基、4-イソキノリル基、5-イソキノリル基)、キノリル基(例:2-キノリル基、3-キノリル基、4-キノリル基、5-キノリル基、8-キノリル基)、シンノリニル基(例:3-シンノリニル基、4-シンノリニル基、5-シンノリニル基、6-シンノリニル基、7-シンノリニル基、8-シンノリニル基)、フタラジニル基(例:1-フタラジニル基、4-フタラジニル基、5-フタラジニル基、6-フタラジニル基、7-フタラジニル基、8-フタラジニル基)、キナゾリニル基(例:2-キナゾリニル基、4-キナゾリニル基、5-キナゾリニル基、6-キナゾリニル基、7-キナゾリニル基、8-キナゾリニル基)、キノキサリニル基(例:2-キノキサリニル基、3-キノキサリニル基、5-キノキサリニル基、6-キノキサリニル基、7-キノキサリニル基、8-キノキサリニル基)、ピラゾロ[1,5-a]ピリジル基(例:ピラゾロ[1,5-a]ピリジン-2-イル基、ピラゾロ[1,5-a]ピリジン-3-イル基、ピラゾロ[1,5-a]ピリジン-4-イル基、ピラゾロ[1,5-a]ピリジン-5-イル基、ピラゾロ[1,5-a]ピリジン-6-イル基、ピラゾロ[1,5-a]ピリジン-7-イル基)、イミダゾ[1,2-a]ピリジル基(例:イミダゾ[1,2-a]ピリジン-2-イル基、イミダゾ[1,2-a]ピリジン-3-イル基、イミダゾ[1,2-a]ピリジン-5-イル基、イミダゾ[1,2-a]ピリジン-6-イル基、イミダゾ[1,2-a]ピリジン-7-イル基、及びイミダゾ[1,2-a]ピリジン-8-イル基)を包含する。 In the present specification, examples of the "5- to 18-membered aromatic condensed heterocyclic group" include isoindolyl groups (e.g., 1-isoindolyl group, 2-isoindolyl group, 3-isoindolyl group, 4-isoindolyl group, 5-isoindolyl group, 6-isoindolyl group, 7-isoindolyl group), indolyl group (e.g. 1-indolyl group, 2-indolyl group, 3-indolyl group, 4-indolyl group, 5-indolyl group, 6-indolyl group, 7- indolyl group), benzo[b]furanyl group (e.g. 2-benzo[b]furanyl group, 3-benzo[b]furanyl group, 4-benzo[b]furanyl group, 5-benzo[b]furanyl group, 6 -benzo[b]furanyl group, 7-benzo[b]furanyl group), benzo[c]furanyl group (e.g. 1-benzo[c]furanyl group, 4-benzo[c]furanyl group, 5-benzo[c ]furanyl group), benzo[b]thienyl group, (e.g. 2-benzo[b]thienyl group, 3-benzo[b]thienyl group, 4-benzo[b]thienyl group, 5-benzo[b]thienyl group , 6-benzo[b]thienyl group, 7-benzo[b]thienyl group), benzo[c]thienyl group (e.g. 1-benzo[c]thienyl group, 4-benzo[c]thienyl group, 5-benzo [c] thienyl group), indazolyl group (e.g., 1-indazolyl group, 2-indazolyl group, 3-indazolyl group, 4-indazolyl group, 5-indazolyl group, 6-indazolyl group, 7-indazolyl group), benzimidazolyl group (e.g. 1-benzimidazolyl group, 2-benzimidazolyl group, 4-benzimidazolyl group, 5-benzimidazolyl group), 1,2-benzisoxazolyl group (e.g. 1,2-benzisoxazol-3-yl group, 1,2-benzisoxazol-4-yl group, 1,2-benzisoxazol-5-yl group, 1,2-benzisoxazol-6-yl group, 1,2-benzisoxazol-7-yl group), benzoxazolyl group (e.g. 2-benzoxazolyl group, 4-benzoxazolyl group, 5-benzoxazolyl group, 6-benzoxazolyl group, 7-benzoxazolyl group ), 1,2-benzisothiazolyl group (e.g., 1,2-benzisothiazol-3-yl group, 1,2-benzisothiazol-4-yl group, 1,2-benzisothiazol-5- yl group, 1,2-benzisothiazol-6-yl group, 1,2-benzisothiazol-7-yl group), benzothiazolyl group (e.g., 2-benzothiazolyl group, 4-benzothiazolyl group, 5-benzothiazolyl group, 6-benzothiazolyl group, 7-benzothiazolyl group), isoquinolyl group (e.g. 1-isoquinolyl group, 3-isoquinolyl group, 4-isoquinolyl group, 5-isoquinolyl group), quinolyl group (e.g. 2-quinolyl group, 3-quinolyl group) group, 4-quinolyl group, 5-quinolyl group, 8-quinolyl group), cinnolinyl group (e.g., 3-cinnolinyl group, 4-cinnolinyl group, 5-cinnolinyl group, 6-cinnolinyl group, 7-cinnolinyl group, 8- cinnolinyl group), phthalazinyl group (e.g. 1-phthalazinyl group, 4-phthalazinyl group, 5-phthalazinyl group, 6-phthalazinyl group, 7-phthalazinyl group, 8-phthalazinyl group), quinazolinyl group (e.g. 2-quinazolinyl group, 4-quinazolinyl group, 5-quinazolinyl group, 6-quinazolinyl group, 7-quinazolinyl group, 8-quinazolinyl group), quinoxalinyl group (e.g., 2-quinoxalinyl group, 3-quinoxalinyl group, 5-quinoxalinyl group, 6-quinoxalinyl group , 7-quinoxalinyl group, 8-quinoxalinyl group), pyrazolo[1,5-a]pyridyl group (e.g., pyrazolo[1,5-a]pyridin-2-yl group, pyrazolo[1,5-a]pyridine- 3-yl group, pyrazolo[1,5-a]pyridin-4-yl group, pyrazolo[1,5-a]pyridin-5-yl group, pyrazolo[1,5-a]pyridin-6-yl group, pyrazolo[1,5-a]pyridin-7-yl group), imidazo[1,2-a]pyridyl group (e.g. imidazo[1,2-a]pyridin-2-yl group, imidazo[1,2- a]pyridin-3-yl group, imidazo[1,2-a]pyridin-5-yl group, imidazo[1,2-a]pyridin-6-yl group, imidazo[1,2-a]pyridine-7 -yl group, and imidazo[1,2-a]pyridin-8-yl group).
2.有害生物防除組成物
 本開示の有害生物防除組成物は、下記式(1):
Figure JPOXMLDOC01-appb-C000005
(式中、
及びRは、それぞれ独立して、水素、1個以上の置換基を有していてもよい炭化水素基、RCO-、又はスルファモイル基(HN-SO-)であり、
は、1個以上の置換基を有していてもよい炭化水素基であり、
Xは、水素、ハロゲン、ニトロ基、シアノ基、1個以上の置換基を有していてもよい炭化水素基、ヘテロアリール基、RO-、RS-、又はRN-であり、
、R、R、及びRは、それぞれ独立して、水素、又は1個以上の置換基を有していてもよい炭化水素基であり、
Zは、水素、ハロゲン、アジド基(-N=N=N)、シアノ基、又はRO-であり、
は、1個以上の置換基を有していてもよい炭化水素基である。)
で表される化合物又はその塩を含有する。
2. Pest control composition The pest control composition of the present disclosure has the following formula (1):
Figure JPOXMLDOC01-appb-C000005
(In the formula,
R 1 and R 2 are each independently hydrogen, a hydrocarbon group optionally having one or more substituents, R 3 CO—, or a sulfamoyl group (H 2 N—SO 2 —); ,
R 3 is a hydrocarbon group optionally having one or more substituents,
X is hydrogen, halogen, nitro group, cyano group, hydrocarbon group optionally having one or more substituents, heteroaryl group, R 4 O—, R 5 S—, or R 6 R 7 N - and
R 4 , R 5 , R 6 and R 7 are each independently hydrogen or a hydrocarbon group optionally having one or more substituents,
Z is hydrogen, halogen, an azide group (-N=N + =N - ), a cyano group, or R 8 O-;
R 8 is a hydrocarbon group optionally having one or more substituents. )
Contains a compound represented by or a salt thereof.
 一実施形態において、R及びRは、それぞれ独立して、水素、1個以上の置換基を有していてもよい炭化水素基、又はRCO-であることが好ましく、水素、1個以上の置換基を有していてもよいアルキル基、1個以上の置換基を有していてもよいアリール基、1個以上の置換基を有していてもよいアラルキル基、又はRCO-であることがより好ましく、水素、1個以上の置換基を有していてもよいアルキル基、又はRCO-であることが更に好ましく、水素、アルキル基、又はRCO-であることが更により好ましく、水素、又はRCO-であることが特に好ましい。 In one embodiment, R 1 and R 2 are each independently preferably hydrogen, a hydrocarbon group optionally having one or more substituents, or R 3 CO—, hydrogen, 1 an alkyl group optionally having one or more substituents, an aryl group optionally having one or more substituents, an aralkyl group optionally having one or more substituents, or R 3 It is more preferably CO—, more preferably hydrogen, an alkyl group optionally having one or more substituents, or R 3 CO—, and hydrogen, an alkyl group, or R 3 CO— is even more preferred, and hydrogen or R 3 CO— is particularly preferred.
 一実施形態において、R及びRは同種の基であることが好ましい。 In one embodiment, R 1 and R 2 are preferably the same group.
 一実施形態において、Rは、1個以上の置換基を有していてもよいアルキル基、1個以上の置換基を有していてもよいアリール基、又は1個以上の置換基を有していてもよいアラルキル基であることが好ましく、1個以上の置換基を有していてもよいアルキル基、又は1個以上の置換基を有していてもよいアリール基であることがより好ましく、1個以上の置換基を有していてもよいアルキル基であることが更に好ましい。当該置換基はヒドロキシル基、メルカプト基、アルコキシ基、又はアルキルチオ基であることが好ましく、アルコキシ基、又はアルキルチオ基であることがより好ましく、アルコキシ基であることが更に好ましい。当該置換基が存在する場合、当該置換基の数は1個以上置換可能な最大数以下から選択され、1個又は2個であることが好ましい。 In one embodiment, R 3 is an alkyl group optionally having one or more substituents, an aryl group optionally having one or more substituents, or It is preferably an aralkyl group that may have one or more substituents, more preferably an alkyl group that may have one or more substituents, or an aryl group that may have one or more substituents. An alkyl group which may have one or more substituents is preferred, and more preferred. The substituent is preferably a hydroxyl group, a mercapto group, an alkoxy group, or an alkylthio group, more preferably an alkoxy group or an alkylthio group, and even more preferably an alkoxy group. When such substituents are present, the number of such substituents is selected from one or more and less than or equal to the maximum substitutable number, and is preferably one or two.
 一実施形態において、Xは、水素、ハロゲン、ニトロ基、シアノ基、アルキル基、アルケニル基、アルキニル基、シクロアルキル基、アリール基、ヘテロアリール基、RO-、RS-、又はRN-であることが好ましく、ハロゲン、シアノ基、又はRO-であることがより好ましく、ハロゲンであることが更に好ましく、フッ素、塩素、又は臭素であることが更により好ましい。 In one embodiment, X is hydrogen, halogen, nitro group, cyano group, alkyl group, alkenyl group, alkynyl group, cycloalkyl group, aryl group, heteroaryl group, R 4 O—, R 5 S—, or R It is preferably 6 R 7 N—, more preferably halogen, a cyano group, or R 4 O—, still more preferably halogen, and even more preferably fluorine, chlorine, or bromine.
 一実施形態において、R、R、R、及びRは、それぞれ独立して、水素、1個以上の置換基を有していてもよいアルキル基、1個以上の置換基を有していてもよいアリール基、又は1個以上の置換基を有していてもよいアラルキル基であることが好ましく、水素、1個以上の置換基を有していてもよいアルキル基、又は1個以上の置換基を有していてもよいアリール基であることがより好ましく、水素、又は1個以上の置換基を有していてもよいアルキル基であることが更に好ましく、水素、又はアルキル基であることが更により好ましい。 In one embodiment, R 4 , R 5 , R 6 and R 7 are each independently hydrogen, an alkyl group optionally having one or more substituents, a or an aralkyl group optionally having one or more substituents, hydrogen, an alkyl group optionally having one or more substituents, or 1 It is more preferably an aryl group optionally having one or more substituents, more preferably hydrogen or an alkyl group optionally having one or more substituents, hydrogen or alkyl is even more preferred.
 一実施形態において、Zは、ハロゲンであることが好ましく、フッ素であることが更に好ましい。 In one embodiment, Z is preferably halogen, more preferably fluorine.
 一実施形態において、Rは、1個以上の置換基を有していてもよいアルキル基、1個以上の置換基を有していてもよいアリール基、又は1個以上の置換基を有していてもよいアラルキル基であることが好ましく、1個以上の置換基を有していてもよいアルキル基、又は1個以上の置換基を有していてもよいアリール基であることがより好ましく、1個以上の置換基を有していてもよいアルキル基であることが更に好ましく、アルキル基であることが更により好ましい。 In one embodiment, R 8 is an alkyl group optionally having one or more substituents, an aryl group optionally having one or more substituents, or It is preferably an aralkyl group that may have one or more substituents, more preferably an alkyl group that may have one or more substituents, or an aryl group that may have one or more substituents. An alkyl group optionally having one or more substituents is preferred, and an alkyl group is even more preferred.
 一実施形態において、R及びRは、それぞれ独立して、水素、又はRCO-であり、Rは、1個以上の置換基(例:アルコキシ基)を有していてもよいアルキル基であり、X及びZは、それぞれ独立して、ハロゲンであることが好ましい。当該実施形態において、Xはフッ素であることが更に好ましい。 In one embodiment, R 1 and R 2 are each independently hydrogen or R 3 CO—, and R 3 may have one or more substituents (eg, alkoxy group) It is an alkyl group, and X and Z are each independently preferably halogen. In such embodiments, it is further preferred that X is fluorine.
 一実施形態において、式(1)で表される化合物又はその塩は、下記式(1-1)~(1-12)からなる群より選択される化合物又はその塩であることが好ましい。 In one embodiment, the compound represented by formula (1) or a salt thereof is preferably a compound or a salt thereof selected from the group consisting of the following formulas (1-1) to (1-12).
Figure JPOXMLDOC01-appb-C000006
Figure JPOXMLDOC01-appb-C000006
 式(1)で表される化合物の塩は、酸付加塩であってもよく塩基付加塩であってもよい。 The salt of the compound represented by formula (1) may be an acid addition salt or a base addition salt.
 前記酸付加塩は無機酸塩であってもよく有機酸塩であってもよい。前記無機酸塩の例は、塩酸、硫酸、リン酸、臭化水素酸、ヨウ化水素酸、硝酸、ピロ硫酸、及びメタリン酸との塩を包含する。前記有機酸塩の例は、クエン酸、安息香酸、酢酸、プロピオン酸、フマル酸、マレイン酸、及びスルホン酸(例:メタンスルホン酸、p-トルエンスルホン酸、及びナフタレンスルホン酸)との塩を包含する。 The acid addition salt may be an inorganic acid salt or an organic acid salt. Examples of the inorganic acid salts include salts with hydrochloric acid, sulfuric acid, phosphoric acid, hydrobromic acid, hydroiodic acid, nitric acid, pyrosulfuric acid, and metaphosphoric acid. Examples of the organic acid salts include salts with citric acid, benzoic acid, acetic acid, propionic acid, fumaric acid, maleic acid, and sulfonic acid (eg, methanesulfonic acid, p-toluenesulfonic acid, and naphthalenesulfonic acid). contain.
 前記塩基付加塩の例は、ナトリウム塩、カリウム塩等のアルカリ金属塩を包含する。 Examples of the base addition salts include alkali metal salts such as sodium salts and potassium salts.
 式(1)で表される化合物又はその塩の製造方法は、特に限定されないが、例えば下記の反応スキームに示すように、式(2)で表される化合物を、式(3)で表される化合物と反応させる工程Aを含むことが好ましい。 The method for producing the compound represented by formula (1) or a salt thereof is not particularly limited. For example, as shown in the reaction scheme below, the compound represented by formula (2) is converted to It is preferable to include a step A of reacting with a compound that
Figure JPOXMLDOC01-appb-C000007
(式中、R1b及びR2bは、それぞれ独立して、ヒドロキシル基の保護基であり、Haloはハロゲンであり、X及びZは前記と同じである。)
Figure JPOXMLDOC01-appb-C000007
(Wherein, R 1b and R 2b are each independently a hydroxyl-protecting group, Halo is a halogen, and X and Z are the same as above.)
 R1b及びR2bで表される保護基としては、一般にヒドロキシル基の保護に用いられているものを全て使用することができる。一実施形態において、R1b及びR2bは、それぞれ独立して、エーテル型保護基(例:t-ブチル基、ベンジル基、トリチル基)、アセタール型保護基(例:テトラヒドロピラニル基)、アシル型保護基(例:アセチル基、ベンゾイル基)、及びシリルエーテル型保護基(例:t-ブチルジメチルシリル基)からなる群より選択することができる。 As the protecting group represented by R 1b and R 2b , all those generally used for protecting hydroxyl groups can be used. In one embodiment, R 1b and R 2b are each independently an ether-type protecting group (eg, t-butyl group, benzyl group, trityl group), an acetal-type protecting group (eg, tetrahydropyranyl group), acyl type protecting group (eg, acetyl group, benzoyl group), and silyl ether type protecting group (eg, t-butyldimethylsilyl group).
 一実施形態において、Haloは臭素又は塩素であることが好ましい。 In one embodiment, Halo is preferably bromine or chlorine.
 式(2)で表される化合物、及び式(3)で表される化合物の各使用量は、反応が進行する限り、特に限定されない。式(2)で表される化合物の使用量に対する式(3)で表される化合物の使用量の比(モル比)の下限は、例えば0.1、0.5、又は1であることができる。当該比の上限は、例えば10、9、8、7、6、又は5であることができる。当該比は、例えば0.1~10、0.5~8、又は1~5であることができる。 The amounts of the compound represented by formula (2) and the compound represented by formula (3) are not particularly limited as long as the reaction proceeds. The lower limit of the ratio (molar ratio) of the amount of the compound represented by formula (3) to the amount of the compound represented by formula (2) is, for example, 0.1, 0.5, or 1. can. The upper limit of the ratio can be 10, 9, 8, 7, 6, or 5, for example. The ratio can be, for example, 0.1-10, 0.5-8, or 1-5.
 工程Aの反応は、塩基の存在下で行うことが好ましい。当該塩基の好適な例は、非求核塩基を包含し、及びその具体例は、金属水素化物(例:カルシウムハイドライド)、及び金属アルコキシド(例:t-ブトキシナトリウム、t-ブトキシカリウム)を包含する。当該塩基は1種を単独で又は2種以上を組み合わせて用いることができる。 The reaction in step A is preferably carried out in the presence of a base. Suitable examples of such bases include non-nucleophilic bases, and specific examples thereof include metal hydrides (eg calcium hydride) and metal alkoxides (eg sodium t-butoxy, potassium t-butoxy). do. The said base can be used individually by 1 type or in combination of 2 or more types.
 工程Aの反応は、溶媒中で行うことが好ましい。当該溶媒の好適な例は、ハロゲン系溶媒(例:ジクロロメタン、クロロホルム、ジクロロエタン)、アルコール系溶媒(例:エタノール、プロパノール、ブタノール、t-アミルアルコール、ペンタノール)、及びニトリル系溶媒(例:アセトニトリル)を包含する。当該溶媒は1種を単独で又は2種以上を組み合わせて用いることができる。 The reaction in step A is preferably carried out in a solvent. Suitable examples of the solvent include halogen solvents (eg, dichloromethane, chloroform, dichloroethane), alcohol solvents (eg, ethanol, propanol, butanol, t-amyl alcohol, pentanol), and nitrile solvents (eg, acetonitrile). ). The said solvent can be used individually by 1 type or in combination of 2 or more types.
 工程Aの反応温度は、反応が進行する限り、特に限定されない。当該反応温度の下限は、例えば5℃、10℃、又は15℃であることができる。当該反応温度の上限は、例えば100℃、90℃、又は80℃であることができる。当該反応温度は、例えば5~100℃、10~90℃、又は15~80℃であることができる。 The reaction temperature in step A is not particularly limited as long as the reaction proceeds. The lower limit of the reaction temperature can be, for example, 5°C, 10°C, or 15°C. The upper limit of the reaction temperature can be, for example, 100°C, 90°C, or 80°C. The reaction temperature can be, for example, 5-100°C, 10-90°C, or 15-80°C.
 式(1)で表される化合物又はその塩の製造方法は、ヒドロキシル基の保護基を脱保護する工程Bを更に含んでいてもよい。工程Bの脱保護は、常法に従って実施することができる。 The method for producing the compound represented by formula (1) or a salt thereof may further include step B of deprotecting the hydroxyl-protecting group. Deprotection in step B can be carried out according to a conventional method.
 別の実施形態において、式(1)で表される化合物又はその製造方法は、
式(3)で表される化合物の代わりに2-アミノ-6-クロロ-9H-プロリンを用いる以外は工程Aと同様に実施する工程D、
工程Dにより得られた生成物を、亜硝酸又は亜硝酸エステル及び臭素源(例:CuBr、CHBr)又はヨウ素源(例:CuI、CH)と反応(ザンドマイヤー反応)させる工程E、並びに
工程Eにより得られた生成物のプリン環の6位をアミノ化し、及びフラン環骨格の3’及び5’位のヒドロキシル基の保護基を脱保護する工程F
を含むことが好ましい。当該方法は、例えば国際公開第2020/213501号を参照することができる。
In another embodiment, the compound represented by formula (1) or a method for producing the same comprises
Step D, carried out in the same manner as Step A, except that 2-amino-6-chloro-9H-proline is used in place of the compound represented by formula (3);
The product obtained from step D is reacted (Sandmeyer reaction ) with nitrite or nitrite ester and a bromine source ( e.g. CuBr, CH2Br2 ) or an iodine source (e.g. CuI, CH2I2 ). Step E, and step F of aminating the 6-position of the purine ring of the product obtained by step E, and deprotecting the protecting groups of the hydroxyl groups at the 3′ and 5′ positions of the furan ring skeleton.
It is preferred to include The method can be referred to, for example, WO2020/213501.
 式(1)で表される化合物又はその製造方法は、工程B又は工程Fで得られた脱保護体を、RCOOH又はそのエステルもしくはハライドと反応させる工程Gを含んでいてもよい。工程Gの反応(エステル化反応)は、常法に従って実施することができる。 The compound represented by formula (1) or the method for producing the same may include step G of reacting the deprotected product obtained in step B or step F with R 3 COOH or its ester or halide. The reaction of step G (esterification reaction) can be carried out according to a conventional method.
 式(1)で表される化合物又はその製造方法において、各工程で得られた生成物は、所望により、ろ過、カラムクロマトグラフィー、濃縮、抽出等の手法により精製してもよい。 In the compound represented by formula (1) or its manufacturing method, the product obtained in each step may be purified by means of filtration, column chromatography, concentration, extraction, etc., if desired.
 有害生物防除組成物中の式(1)で表される化合物又はその塩の含有量は、有害生物防除に対する有効量であることが好ましい。当該含有量の下限は、有害生物防除組成物100質量部に対して、例えば0.01質量部、0.05質量部、0.1質量部、0.5質量部、1質量部、5質量部、又は10質量部であることができる。当該含有量の上限は、有害生物防除組成物100質量部に対して、例えば99質量部、90質量部、85質量部、80質量部、75質量部、70質量部、65質量部、60質量部、55質量部、又は50質量部であることができる。当該含有量は、有害生物防除組成物100質量部に対して、例えば0.01~99質量部、0.05~90質量部、又は0.1~80質量部であることができる。 The content of the compound represented by formula (1) or a salt thereof in the pest control composition is preferably an effective amount for controlling pests. The lower limit of the content is, for example, 0.01 parts by mass, 0.05 parts by mass, 0.1 parts by mass, 0.5 parts by mass, 1 part by mass, and 5 parts by mass with respect to 100 parts by mass of the pest control composition. parts, or 10 parts by weight. The upper limit of the content is, for example, 99 parts by mass, 90 parts by mass, 85 parts by mass, 80 parts by mass, 75 parts by mass, 70 parts by mass, 65 parts by mass, 60 parts by mass with respect to 100 parts by mass of the pest control composition. parts, 55 parts by weight, or 50 parts by weight. The content can be, for example, 0.01 to 99 parts by mass, 0.05 to 90 parts by mass, or 0.1 to 80 parts by mass with respect to 100 parts by mass of the pest control composition.
 有害生物防除組成物は、式(1)で表される化合物又はその塩、及び担体を含有することが好ましい。当該担体は、固体担体、液体担体、及びガス状担体のいずれであってもよい。 The pest control composition preferably contains the compound represented by formula (1) or a salt thereof, and a carrier. The carrier may be a solid carrier, a liquid carrier, or a gaseous carrier.
 固体担体としては、例えば、活性炭、シリカ、タルク、二酸化チタン、ゼオライト、炭酸カルシウム、リン酸カルシウム等の無機粒子;カオリン、珪藻土、ベントナイト、クレー、酸性白土等の粘土鉱物;ポリエチレン、ポリプロピレン、ポリ塩化ビニリデン等のポリマー粒子;肥料;木粉等が挙げられる。 Examples of solid carriers include inorganic particles such as activated carbon, silica, talc, titanium dioxide, zeolite, calcium carbonate, and calcium phosphate; clay minerals such as kaolin, diatomaceous earth, bentonite, clay, and acid clay; polyethylene, polypropylene, polyvinylidene chloride, and the like. polymer particles; fertilizers; wood flour and the like.
 液体担体としては、例えば、水(例:水道水、イオン交換水、蒸留水、滅菌水)、アルコール類(例:メタノール、エタノール、イソプロパノール、ブタノール、エチレングリコール、プロピレングリコール)、エーテル類(例:ジエチルエーテル、メチルセロソルブ、エチルセロソルブ、ジメチルセロソルブ、ジエチレングリコールモノメチルエーテル、ジエチレングリコールモノエチルエーテル、テトラヒドロフラン、ジオキサン)、エステル類(例:酢酸エチル、フタル酸ジエチル)、ケトン類(例:アセトン、メチルエチルケトン、メチルイソブチルケトン、シクロヘキサノン)、脂肪族炭化水素類(例:ケロシン、鉱油)、芳香族炭化水素類(例:キシレン、トルエン、アルキルナフタレン)、ハロゲン化炭化水素類(例:ジクロロメタン、ジクロロエタン、クロロホルム等)、ニトリル類(例:アセトニトリル、イソブチロニトリル)、スルホキシド類(例:ジメチルスルホキシド)、アミド類(例:N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド)、植物油等が挙げられる。 Liquid carriers include, for example, water (e.g. tap water, ion-exchanged water, distilled water, sterilized water), alcohols (e.g. methanol, ethanol, isopropanol, butanol, ethylene glycol, propylene glycol), ethers (e.g. diethyl ether, methyl cellosolve, ethyl cellosolve, dimethyl cellosolve, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, tetrahydrofuran, dioxane), esters (e.g. ethyl acetate, diethyl phthalate), ketones (e.g. acetone, methyl ethyl ketone, methyl isobutyl) ketone, cyclohexanone), aliphatic hydrocarbons (e.g. kerosene, mineral oil), aromatic hydrocarbons (e.g. xylene, toluene, alkylnaphthalene), halogenated hydrocarbons (e.g. dichloromethane, dichloroethane, chloroform, etc.), nitriles (eg, acetonitrile, isobutyronitrile), sulfoxides (eg, dimethylsulfoxide), amides (eg, N,N-dimethylformamide, N,N-dimethylacetamide), vegetable oils and the like.
 ガス状担体としては、例えば、ブタンガス;フロンガス;HFO、HFC等の代替フロンガス;液化石油ガス(LPG);炭酸ガス等が挙げられる。 Examples of gaseous carriers include butane gas; freon gas; alternative freon gases such as HFO and HFC; liquefied petroleum gas (LPG);
 前記担体は1種を単独で又は2種以上を組み合わせて用いることができる。一実施形態において、前記担体は固体担体又は液体担体である。 The carriers can be used singly or in combination of two or more. In one embodiment, the carrier is a solid carrier or a liquid carrier.
 式(1)で表される化合物又はその塩の含有量に対する前記担体の含有量の比(質量比)の下限は、例えば0.1、0.5、又は1であることができる。当該比の上限は、例えば、1000、900、800、700、600、500、400、300、200、100、50、又は10であることができる。当該比は、例えば0.1~1000、0.5~500、又は1~100であることができる。 The lower limit of the ratio (mass ratio) of the content of the carrier to the content of the compound represented by formula (1) or a salt thereof can be 0.1, 0.5, or 1, for example. The upper limit of the ratio can be 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, or 10, for example. The ratio can be, for example, 0.1-1000, 0.5-500, or 1-100.
 有害生物防除組成物は、任意の追加成分(又は補助剤)を更に含有することができる。当該追加成分の一例として、界面活性剤が挙げられる。界面活性剤は、ノニオン性界面活性剤、アニオン性界面活性剤、カチオン性界面活性剤、及び両性界面活性剤のいずれであってもよい。 The pest control composition can further contain optional additional ingredients (or adjuvants). An example of such additional ingredients is a surfactant. Surfactants may be any of nonionic surfactants, anionic surfactants, cationic surfactants, and amphoteric surfactants.
 ノニオン性界面活性剤としては、例えば、脂肪酸ジアルカノールアミド(例:ラウリン酸ジエタノールアミド)、ポリオキシアルキレン脂肪酸アミド(例:ポリオキシエチレンステアリン酸アミド)、ポリオキシアルキレンアリールエーテル(例:ポリオキシエチレンフェニルエーテル)、ポリオキシアルキレンアルキルアリールエーテル(例:ポリオキシエチレンオクチルフェニルエーテル)、ポリオキシアルキレンアルキル又はアルケニルエーテル(例:ポリオキシエチレンラウリルエーテル、ポリオキシエチレンステアリルエーテル)、多価アルコールの脂肪酸エステル(例:ポリエチレングリコールモノ又はジステアリン酸エステル、ポリエチレングリコールモノ又はジラウリン酸エステル、ポリオキシエチレン硬化ヒマシ油)、グリセリン脂肪酸エステル(例:モノステアリン酸グリセリン、モノオレイン酸グリセリン)、ソルビタン脂肪酸エステル(例:モノラウリル酸ソルビタン、モノステアリン酸ソルビタン)、ポリオキシエチレン-ポリオキシプロピレンブロックポリマー等が挙げられる。 Examples of nonionic surfactants include fatty acid dialkanolamides (e.g. lauric acid diethanolamide), polyoxyalkylene fatty acid amides (e.g. polyoxyethylene stearamide), polyoxyalkylene aryl ethers (e.g. polyoxyethylene phenyl ether), polyoxyalkylene alkyl aryl ethers (e.g. polyoxyethylene octylphenyl ether), polyoxyalkylene alkyl or alkenyl ethers (e.g. polyoxyethylene lauryl ether, polyoxyethylene stearyl ether), fatty acid esters of polyhydric alcohols (Example: polyethylene glycol mono- or distearate, polyethylene glycol mono- or dilaurate, polyoxyethylene hydrogenated castor oil), glycerin fatty acid ester (eg: glyceryl monostearate, glyceryl monooleate), sorbitan fatty acid ester (eg: sorbitan monolaurate, sorbitan monostearate), polyoxyethylene-polyoxypropylene block polymers, and the like.
 アニオン性界面活性剤としては、例えば、アルカンスルホン酸(例:ドデカンスルホン酸)、アレーンスルホン酸(例:ドデシルベンゼンスルホン酸)、ポリアルキレングリコールスルホン酸(例:ポリエチレングリコールスルホン酸)、アルキル硫酸(例:ラウリル硫酸)、ポリオキシアルキレンアルキルエーテル硫酸(例:ポリオキシエチレンラウリルエーテル硫酸)、ポリオキシアルキレンアルキルアリールエーテル硫酸(例:ポリオキシエチレンアルキルフェニルエーテル硫酸)、アルキルリン酸(例:ラウリルリン酸)、ポリオキシアルキレンアルキルエーテルリン酸(例:ポリオキシエチレンラウリルエーテルリン酸)、ポリオキシアルキレンアリールエーテルリン酸(例:ポリオキシエチレンフェニルエーテルリン酸)、又はこれらの塩(ナトリウム塩等のアルカリ金属塩)、及び長鎖脂肪酸塩(例:ステアリン酸カルシウム、ステアリン酸マグネシウム、モノステアリン酸アルミニウム塩、ステアリン酸トリエタノールアミン、オレイン酸トリエタノールアミン)等が挙げられる。 Examples of anionic surfactants include alkanesulfonic acid (e.g. dodecanesulfonic acid), arenesulfonic acid (e.g. dodecylbenzenesulfonic acid), polyalkylene glycol sulfonic acid (e.g. polyethylene glycol sulfonic acid), alkyl sulfate ( lauryl sulfate), polyoxyalkylene alkyl ether sulfate (eg, polyoxyethylene lauryl ether sulfate), polyoxyalkylene alkyl aryl ether sulfate (eg, polyoxyethylene alkylphenyl ether sulfate), alkyl phosphate (eg, lauryl phosphorus acid), polyoxyalkylene alkyl ether phosphate (e.g. polyoxyethylene lauryl ether phosphate), polyoxyalkylene aryl ether phosphate (e.g. polyoxyethylene phenyl ether phosphate), or salts thereof (such as sodium salts alkali metal salts), and long-chain fatty acid salts (eg, calcium stearate, magnesium stearate, aluminum monostearate, triethanolamine stearate, triethanolamine oleate), and the like.
 カチオン性界面活性剤としては、例えば、テトラアルキルアンモニウム塩(例:ラウリルトリメチルアンモニウムクロライド、ジラウリルジメチルアンモニウムクロライド)、トリアルキルアンモニウム塩(例:ラウリルジメチルベンジルアンモニウムクロライド、塩化ベンザルコニウム)、トリ(ポリオキシアルキレンアルキル)アンモニウム塩(例:トリ(ポリオキシエチレンステアリル)アンモニウムクロライド)等が挙げられる。 Examples of cationic surfactants include tetraalkylammonium salts (eg, lauryltrimethylammonium chloride, dilauryldimethylammonium chloride), trialkylammonium salts (eg, lauryldimethylbenzylammonium chloride, benzalkonium chloride), tri( polyoxyalkylenealkyl)ammonium salts (eg, tri(polyoxyethylenestearyl)ammonium chloride) and the like.
 両性界面活性剤としては、例えば、ベタイン類(例:ベタイン;ジメチルドデシルカルボキシベタイン等のアルキルベタイン)、ホスファチジン酸誘導体(例:レシチン、リゾレシチン、ホスファチジルエタノールアミン)、ジメチルアルキルアミンオキシド等が挙げられる。 Examples of amphoteric surfactants include betaines (eg, betaine; alkylbetaines such as dimethyldodecylcarboxybetaine), phosphatidic acid derivatives (eg, lecithin, lysolecithin, phosphatidylethanolamine), dimethylalkylamine oxides, and the like.
 界面活性剤は1種を単独で又は2種以上を組み合わせて用いることができる。式(1)で表される化合物又はその塩の含有量に対する界面活性剤の含有量の比(質量比)の下限は、例えば0.1、0.5、又は1であることができる。当該比の上限は、例えば、1000、900、800、700、600、500、400、300、200、100、50、又は10であることができる。当該比は、例えば0.1~1000、0.5~500、又は1~100であることができる。 The surfactants can be used singly or in combination of two or more. The lower limit of the ratio (mass ratio) of the content of the surfactant to the content of the compound represented by formula (1) or a salt thereof can be 0.1, 0.5, or 1, for example. The upper limit of the ratio can be 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, or 10, for example. The ratio can be, for example, 0.1-1000, 0.5-500, or 1-100.
 前記追加成分の別の例として、不凍剤、消泡剤、防腐剤、酸化防止剤、増粘剤、着色剤、可塑剤、潤滑剤、分散剤、緩衝剤、微量元素が挙げられる。 Other examples of the additional ingredients include antifreeze agents, antifoaming agents, preservatives, antioxidants, thickeners, colorants, plasticizers, lubricants, dispersants, buffers, and trace elements.
 有害生物防除組成物は、例えば、
粉剤[例:式(1)で表される化合物又はその塩0.1~10質量%及び固体担体90~99.9質量%を含有する粉剤]、
顆粒剤[例:式(1)で表される化合物又はその塩0.1~30質量%及び固体担体70~99.5質量%を含有する顆粒剤]、
水和剤[例:式(1)で表される化合物又はその塩0.5~90質量%、固体担体5~95質量%、及び界面活性剤0.5~20質量%を含有する水和剤]、
懸濁液濃縮物[例:式(1)で表される化合物又はその塩5~75質量%、液体担体24~94質量%、及び界面活性剤1~40質量%を含有する懸濁液濃縮物]、又は
乳化性濃縮物[例:式(1)で表される化合物又はその塩1~95質量%、液体担体1~80質量%、及び界面活性剤1~30質量%を含有する懸濁液濃縮物]
であることができる。
The pest control composition is, for example,
powders [e.g., powders containing 0.1 to 10% by mass of the compound represented by formula (1) or a salt thereof and 90 to 99.9% by mass of a solid carrier],
granules [e.g. granules containing 0.1 to 30% by mass of the compound represented by formula (1) or a salt thereof and 70 to 99.5% by mass of solid carrier],
Wettable powder [e.g., a hydrating agent containing 0.5 to 90% by mass of a compound represented by formula (1) or a salt thereof, 5 to 95% by mass of a solid carrier, and 0.5 to 20% by mass of a surfactant agent],
Suspension concentrate [Example: Suspension concentrate containing 5 to 75% by mass of the compound represented by formula (1) or a salt thereof, 24 to 94% by mass of liquid carrier, and 1 to 40% by mass of surfactant product], or an emulsifiable concentrate [e.g., a suspension containing 1 to 95% by mass of a compound represented by formula (1) or a salt thereof, 1 to 80% by mass of a liquid carrier, and 1 to 30% by mass of a surfactant Turbidity Concentrate]
can be
 有害生物防除組成物により防除可能な有害生物は、例えば病害虫又は病原菌であることができ、植物に対する病害虫又は病原菌であることが好ましい。 The pests that can be controlled by the pest control composition can be, for example, pests or pathogens, and are preferably pests or pathogens for plants.
 前記病害虫としては、例えば、昆虫、線虫、ダニ、マダニ等が挙げられるが、これらに限定されない。前記病害虫は、下表に示す系統又は分類に属する病害虫であることが好ましい。
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-I000009
Figure JPOXMLDOC01-appb-I000010
Figure JPOXMLDOC01-appb-I000011
Examples of pests include, but are not limited to, insects, nematodes, mites, and ticks. The pests are preferably pests belonging to the systems or classifications shown in the table below.
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-I000009
Figure JPOXMLDOC01-appb-I000010
Figure JPOXMLDOC01-appb-I000011
 前記病害虫は、鱗翅目害虫又は半翅目害虫であることが更に好ましく、鱗翅目害虫であることが更により好ましく、コナガ科害虫及びヤガ科害虫からなる群より選択される少なくとも一種であることが特に好ましい。 The pest is more preferably a lepidopteran pest or a hemiptera pest, even more preferably a lepidopteran pest, and is at least one selected from the group consisting of diamondback moth pests and noctuid pests. Especially preferred.
 前記病原菌としては、例えば、いもち病原菌、紋枯病原菌、炭疽病原菌、疫病原菌、うどんこ病原菌、褐斑病原菌、かび病原菌(例:灰色かび病原菌)、さび病原菌、黒星病原菌、褐条病原菌、馬鹿苗病原菌、苗立枯病原菌、もみ枯病原菌、軟腐病原菌、かいよう病原菌、黒腐病原菌、腐敗病原菌、花雷腐敗病原菌、根こぶ病原菌、青枯病原菌、根腐萎凋病原菌、つる割病原菌、黄化萎縮病原菌、葉枯病原菌、黒穂病原菌などが挙げられるが、これらに限定されない。 Examples of the pathogens include rice blast pathogens, crest pathogens, anthrax pathogens, plague pathogens, powdery mildew pathogens, brown spot pathogens, mold pathogens (e.g. gray mold pathogens), rust pathogens, black star pathogens, brown streak pathogens, and banae. Pathogens, seedling wilt pathogens, rice rot pathogens, soft rot pathogens, canker pathogens, black rot pathogens, rot pathogens, flower thunder rot pathogens, root-knot pathogens, bacterial wilt pathogens, root rot pathogens, vine split pathogens, yellowing wilt pathogens , leaf blight pathogen, smut pathogen, and the like, but are not limited to these.
 前記病原菌は、いもち病原菌、紋枯病原菌、炭疽病原菌、及び褐斑病原菌からなる群より選択される少なくとも一種であることが好ましい。 The pathogen is preferably at least one selected from the group consisting of rice blast pathogen, sheath blight pathogen, anthrax pathogen, and brown spot pathogen.
 有害生物防除組成物により防除可能な有害生物が、植物に対する病害虫又は病原菌である場合、当該植物は、植物の全体であっても一部であってもよい。植物の一部の例は、茎、葉、花、穂、果実、幹、枝、種子、根、芽、及び苗を包含する。 When the pest controllable by the pest control composition is a plant pest or pathogen, the plant may be a whole plant or a part of the plant. Examples of plant parts include stems, leaves, flowers, ears, fruits, stems, branches, seeds, roots, shoots, and seedlings.
 前記植物の例は、イネ科植物(例:イネ、オオムギ、コムギ、トウモロコシ、エンバク)、アブラナ科植物(例:ダイコン、カブ、ハクサイ、キャベツ、シロナ、ミズナ、ミブナ、コマツナ、ブロッコリー、カリフラワー)、ウリ科植物(例:カボチャ、キュウリ、シロウリ、スイカ、トウガン、メロン)、ナス科植物(例:ピーマン、ナス、トマト、トウガラシ、ジャガイモ、シシトウ)、セリ科植物(例:ニンジン、パセリ、ミツバ、セロリ)、ユリ科植物(例:ネギ、タマネギ、ニラ、ワケギ、ラッキョウ)、キク科植物(例:キク、シュンギク、ゴボウ、ヒマワリ、レタス、フキ、ベビーリーフ)、アカザ科植物(例:ホウレンソウ、フダンソウ)、ヒルガオ科植物(例:サツマイモ)、マメ科植物(例:エンドウ、ダイズ、ソラマメ、エダマメ、インゲン、ラッカセイ)、バラ科植物(例:イチゴ、モモ、スモモ、リンゴ、ナシ)、及びブドウ科植物(例:ブドウ)を包含する。 Examples of the plants include gramineous plants (e.g., rice, barley, wheat, corn, oats), cruciferous plants (e.g., Japanese radish, turnip, Chinese cabbage, cabbage, white mustard, mizuna, mibuna, Japanese mustard spinach, broccoli, cauliflower), Cucurbitaceous plants (e.g. pumpkin, cucumber, white mustard, watermelon, castor bean, melon), solanaceous plants (e.g. peppers, eggplants, tomatoes, peppers, potatoes, green peppers), umbelliferous plants (e.g. carrots, parsley, mitsuba, celery), Liliaceae plants (e.g. green onions, onions, chives, spring onions, shallots), Asteraceae plants (e.g. chrysanthemums, chrysanthemums, burdocks, sunflowers, lettuce, butterbur, baby leaves), Chenopodiaceae plants (e.g. spinach, Swiss chard), bindweed (e.g. sweet potato), legumes (e.g. peas, soybeans, fava beans, edamame, kidney beans, peanuts), roses (e.g. strawberries, peaches, plums, apples, pears), and grapes Includes family plants (eg grapes).
 当該植物は、イネ科植物、アブラナ科植物、ウリ科植物、マメ科植物、バラ科植物、及びブドウ科植物からなる群より選択される少なくとも一種であることが好ましく、イネ科植物、アブラナ科植物、ウリ科植物、及びマメ科植物からなる群より選択される少なくとも一種であることが更に好ましい。 The plant is preferably at least one selected from the group consisting of gramineous plants, cruciferous plants, cucurbitaceous plants, leguminous plants, rosaceous plants, and vine plants. , cucurbitaceous plants, and legumes.
 一実施形態において、有害生物防除組成物は、有害生物に直接施用してもよく、有害生物の生息場所又は生息(もしくは発生)し得る場所に施用してもよい。有害生物の生息場所又は生息し得る場所としては、例えば、農作物や観葉植物等を育成する場所(例:ビニールハウス、果樹園、畑、庭、プランタ)、農作物や観葉植物等を保管する場所(例:厨房、倉庫)等が挙げられる。 In one embodiment, the pest control composition may be applied directly to the pest, or applied to a place where the pest lives or can live (or generate). Examples of places where harmful organisms live or can live include places where agricultural products and foliage plants are grown (e.g. vinyl greenhouses, orchards, fields, gardens, planters), places where agricultural products and foliage plants are stored ( Examples: kitchens, warehouses), etc.
 一実施形態において、有害生物防除組成物は、植物(全体又は一部)に直接施用してもよく、植物を栽培する土壌に施用してもよい。 In one embodiment, the pest control composition may be applied directly to the plant (in whole or in part) or to the soil in which the plant is grown.
 施用方法としては、一般に有害生物防除組成物の施用で採用されている方法を全て採用することができ、例えば、塗布又は散布であることができる。有害生物防除組成物の施用量の下限は、適用面積1ha当たり、例えば1g、5g、10g、15g、20g、25g、30g、35g、40g、45g、50g、100g、200g、300g、400g、又は500gであることができる。当該施用量の上限は、1ha当たり、例えば、10000g、9000g、8000g、7000g、6000g、5000g、4000g、3000g、2000gであることができる。当該施用量は、1ha当たり、例えば1~10000g、5~9000g、又は10~8000gであることができる。 As for the application method, all the methods generally employed for application of pest control compositions can be employed, for example, application or spraying. The lower limit of the application amount of the pest control composition is, for example, 1 g, 5 g, 10 g, 15 g, 20 g, 25 g, 30 g, 35 g, 40 g, 45 g, 50 g, 100 g, 200 g, 300 g, 400 g, or 500 g per hectare of application area. can be The upper limit of the application amount can be, for example, 10,000 g, 9,000 g, 8,000 g, 7,000 g, 6,000 g, 5,000 g, 4,000 g, 3,000 g, and 2,000 g per ha. The application rate can be, for example, 1-10000 g, 5-9000 g, or 10-8000 g per ha.
3.式(1a)で表される化合物又はその塩
 本開示は、下記式(1a):
Figure JPOXMLDOC01-appb-C000012
(式中、
1a及びR2aは、それぞれ独立して、1個以上の置換基を有していてもよい炭化水素基、R3aCO-、又はスルファモイル基であり、
3aは、1個以上の置換基を有していてもよい炭化水素基であり、
は、ハロゲン、ニトロ基、シアノ基、1個以上の置換基を有していてもよい炭化水素基、ヘテロアリール基、R4aO-、又はR5aS-であり、
4a及びR5aは、それぞれ、水素、又は1個以上の置換基を有していてもよい炭化水素基であり、
は、ハロゲン、アジド基、シアノ基、又はR8aO-であり、
8aは、1個以上の置換基を有していてもよい炭化水素基である。)
で表される化合物又はその塩を包含する。
3. The compound represented by formula (1a) or a salt thereof in the present disclosure is represented by the following formula (1a):
Figure JPOXMLDOC01-appb-C000012
(In the formula,
R 1a and R 2a are each independently a hydrocarbon group optionally having one or more substituents, R 3a CO—, or a sulfamoyl group,
R 3a is a hydrocarbon group optionally having one or more substituents,
X a is a halogen, a nitro group, a cyano group, a hydrocarbon group optionally having one or more substituents, a heteroaryl group, R 4a O—, or R 5a S—;
R 4a and R 5a are each hydrogen or a hydrocarbon group optionally having one or more substituents,
Z a is a halogen, an azide group, a cyano group, or R 8a O—;
R 8a is a hydrocarbon group optionally having one or more substituents. )
The compound represented by or its salt is included.
 一実施形態において、R1a及びR2aは、それぞれ独立して、1個以上の置換基を有していてもよい炭化水素基、又はR3aCO-であることが好ましく、1個以上の置換基を有していてもよいアルキル基、1個以上の置換基を有していてもよいアリール基、1個以上の置換基を有していてもよいアラルキル基、又はR3aCO-であることがより好ましく、1個以上の置換基を有していてもよいアルキル基、又はR3aCO-であることが更に好ましく、アルキル基、又はR3aCO-であることが更により好ましく、R3aCO-であることが特に好ましい。 In one embodiment, R 1a and R 2a are each independently a hydrocarbon group optionally having one or more substituents, or R 3a CO—, preferably one or more substituted an alkyl group optionally having a group, an aryl group optionally having one or more substituents, an aralkyl group optionally having one or more substituents, or R 3a CO— more preferably an alkyl group optionally having one or more substituents, or R 3a CO—, even more preferably an alkyl group or R 3a CO—, and R 3a CO— is particularly preferred.
 一実施形態において、R1a及びR2aは同種の基であることが好ましい。 In one embodiment, R 1a and R 2a are preferably the same group.
 一実施形態において、R3aは、1個以上の置換基を有していてもよいアルキル基、1個以上の置換基を有していてもよいアリール基、又は1個以上の置換基を有していてもよいアラルキル基であることが好ましく、1個以上の置換基を有していてもよいアルキル基、又は1個以上の置換基を有していてもよいアリール基であることがより好ましく、1個以上の置換基を有していてもよいアルキル基であることが更に好ましい。当該置換基はヒドロキシル基、メルカプト基、アルコキシ基、又はアルキルチオ基であることが好ましく、アルコキシ基、又はアルキルチオ基であることがより好ましく、アルコキシ基であることが更に好ましい。当該置換基の数は1個以上置換可能な最大数以下であればよく、1個又は2個であることが好ましい。 In one embodiment, R 3a is an alkyl group optionally having one or more substituents, an aryl group optionally having one or more substituents, or It is preferably an aralkyl group that may have one or more substituents, more preferably an alkyl group that may have one or more substituents, or an aryl group that may have one or more substituents. An alkyl group which may have one or more substituents is preferred, and more preferred. The substituent is preferably a hydroxyl group, a mercapto group, an alkoxy group, or an alkylthio group, more preferably an alkoxy group or an alkylthio group, and even more preferably an alkoxy group. The number of the substituents may be one or more and not more than the maximum substitutable number, preferably one or two.
 一実施形態において、Xは、ハロゲン、ニトロ基、シアノ基、アルキル基、アルケニル基、アルキニル基、シクロアルキル基、アリール基、ヘテロアリール基、R4aO-、又はR5aS-であることが好ましく、ハロゲン、シアノ基、又はR4aO-であることがより好ましく、ハロゲンであることが更に好ましく、フッ素、塩素、又は臭素であることが更により好ましい。 In one embodiment, X a is a halogen, nitro group, cyano group, alkyl group, alkenyl group, alkynyl group, cycloalkyl group, aryl group, heteroaryl group, R 4a O—, or R 5a S— is preferred, halogen, a cyano group, or R 4a O— is more preferred, halogen is even more preferred, and fluorine, chlorine, or bromine is even more preferred.
 一実施形態において、R4a及びR5aは、それぞれ、水素、1個以上の置換基を有していてもよいアルキル基、1個以上の置換基を有していてもよいアリール基、又は1個以上の置換基を有していてもよいアラルキル基であることが好ましく、水素、1個以上の置換基を有していてもよいアルキル基、又は1個以上の置換基を有していてもよいアリール基であることがより好ましく、水素、又は1個以上の置換基を有していてもよいアルキル基であることが更に好ましく、水素、又はアルキル基であることが更により好ましい。 In one embodiment, R 4a and R 5a are each hydrogen, an alkyl group optionally having one or more substituents, an aryl group optionally having one or more substituents, or 1 It is preferably an aralkyl group optionally having one or more substituents, such as hydrogen, an alkyl group optionally having one or more substituents, or having one or more substituents It is more preferably an aryl group that may be substituted, more preferably hydrogen or an alkyl group optionally having one or more substituents, and even more preferably hydrogen or an alkyl group.
 一実施形態において、Zは、ハロゲンであることが好ましく、フッ素であることが更に好ましい。 In one embodiment, Z a is preferably halogen, more preferably fluorine.
 一実施形態において、R8aは、1個以上の置換基を有していてもよいアルキル基、1個以上の置換基を有していてもよいアリール基、又は1個以上の置換基を有していてもよいアラルキル基であることが好ましく、1個以上の置換基を有していてもよいアルキル基、又は1個以上の置換基を有していてもよいアリール基であることがより好ましく、1個以上の置換基を有していてもよいアルキル基であることが更に好ましく、アルキル基であることが更により好ましい。 In one embodiment, R 8a is an alkyl group optionally having one or more substituents, an aryl group optionally having one or more substituents, or It is preferably an aralkyl group that may have one or more substituents, more preferably an alkyl group that may have one or more substituents, or an aryl group that may have one or more substituents. An alkyl group optionally having one or more substituents is preferred, and an alkyl group is even more preferred.
 一実施形態において、R1a及びR2aは、それぞれ独立して、R3aCO-であり、R3aは、1個以上の置換基(例:アルコキシ基)を有していてもよいアルキル基であり、X及びZは、それぞれ独立して、ハロゲンであることが好ましく、R1a及びR2aは、それぞれ独立して、R3aCO-であり、R3aは、1個以上の置換基(例:アルコキシ基)を有していてもよいアルキル基であり、Xはフッ素であり、Zはハロゲンであることが更に好ましい。 In one embodiment, R 1a and R 2a are each independently R 3a CO—, and R 3a is an alkyl group optionally having one or more substituents (eg, an alkoxy group). and X a and Z a are each independently preferably halogen, R 1a and R 2a are each independently R 3a CO—, and R 3a is one or more substituents It is an alkyl group optionally having (eg, an alkoxy group), X a is fluorine, and Z a is more preferably halogen.
 一実施形態において、式(1a)で表される化合物又はその塩は、下記式(1a-1)~(1a-9)からなる群より選択される化合物又はその塩であることが好ましい。 In one embodiment, the compound represented by formula (1a) or a salt thereof is preferably a compound or a salt thereof selected from the group consisting of the following formulas (1a-1) to (1a-9).
Figure JPOXMLDOC01-appb-C000013
Figure JPOXMLDOC01-appb-C000013
 式(1a)で表される化合物の塩は、例えば式(1)で表される化合物の塩で例示した酸又は塩基との塩であることができる。 The salt of the compound represented by formula (1a) can be, for example, a salt with an acid or base exemplified for the salt of the compound represented by formula (1).
 式(1a)で表される化合物又はその塩は、例えば式(1)で表される化合物又はその塩と同様に製造することができる。 The compound represented by formula (1a) or a salt thereof can be produced, for example, in the same manner as the compound represented by formula (1) or a salt thereof.
 以下、実施例によって本開示の一実施態様を更に詳細に説明するが、本開示はこれに限定されるものではない。なお、本実施例において、略号「Bz」はベンゾイル基を意味する。 An embodiment of the present disclosure will be described in more detail below by way of examples, but the present disclosure is not limited thereto. In addition, the abbreviation "Bz" means a benzoyl group in the present Examples.
(実施例1)
 2-デオキシ-2-フルオロ-1,3,5-トリ-O-ベンゾイル-α-D-アラビノフラノース 5g(10.8mmol)を脱水ジクロロメタン 20 mLに溶解後、臭化水素-酢酸溶液(5.1 mol/L) 4.8 mL(24.5 mmol)を滴下し、16時間攪拌した。反応溶液にクロロホルムを加えた後、水、飽和炭酸水素ナトリウム水溶液、飽和食塩水の順に洗浄後、硫酸ナトリウムを加えて乾燥させた。この溶液をろ過した後、濃縮乾固することで化合物1を4.56g得た。
(Example 1)
After dissolving 5 g (10.8 mmol) of 2-deoxy-2-fluoro-1,3,5-tri-O-benzoyl-α-D-arabinofuranose in 20 mL of dehydrated dichloromethane, hydrogen bromide-acetic acid solution (5.1 mol /L) 4.8 mL (24.5 mmol) was added dropwise and stirred for 16 hours. After adding chloroform to the reaction solution, the reaction solution was washed with water, a saturated aqueous solution of sodium hydrogencarbonate and saturated brine in that order, and dried by adding sodium sulfate. After filtering this solution, 4.56g of compounds 1 were obtained by concentration-drying.
Figure JPOXMLDOC01-appb-C000014
Figure JPOXMLDOC01-appb-C000014
1H NMR (CDCl3, 400 MHz) δ: 4.70-4.83 (m, 3 H), 5.50-5.65 (m, 2 H), 6.61 and 6.65 (d×2, 1 H), 7.42-7.62 (m, 6 H), 8.04-8.11 (m, 4 H).19F NMR (CDCl3, 400 MHz) δ: -165.73-165.95. 1 H NMR (CDCl 3 , 400 MHz) δ: 4.70-4.83 (m, 3 H), 5.50-5.65 (m, 2 H), 6.61 and 6.65 (d×2, 1 H), 7.42-7.62 (m, 6 H), 8.04-8.11 (m, 4 H). 19 F NMR (CDCl 3 , 400 MHz) δ: -165.73-165.95.
 t-ブトキシカリウム 0.477g(4.25mmol)、カルシウムハイドライド 0.179g(4.25mmol)をt-アミルアルコール 20 mL、脱水アセトニトリル 4 mLに溶解後、2-クロロアデニン 0.721g(4.25 mmol)を添加した。続いて、化合物1 1.2g(2.84 mmol)を脱水アセトニトリル 6 mLに溶解したものを滴下した。滴下後、50℃で16時間攪拌した。反応溶液に酢酸エチルを加えてろ過後、カラム精製を行うことで化合物2を0.327g得た。 After dissolving 0.477 g (4.25 mmol) of t-butoxypotassium and 0.179 g (4.25 mmol) of calcium hydride in 20 mL of t-amyl alcohol and 4 mL of dehydrated acetonitrile, 0.721 g (4.25 mmol) of 2-chloroadenine was added. Subsequently, a solution of 1.2 g (2.84 mmol) of compound 1 dissolved in 6 mL of dehydrated acetonitrile was added dropwise. After dropping, the mixture was stirred at 50°C for 16 hours. 0.327g of compound 2 was obtained by performing column refinement|purification after adding ethyl acetate to the reaction solution and filtering.
Figure JPOXMLDOC01-appb-C000015
Figure JPOXMLDOC01-appb-C000015
1H NMR (CDCl3, 400 MHz) δ: 4.55-4.57 (m, 1 H), 4.79-4.80 (m, 2 H), 5.28 and 5.40 (d×2, 1 H), 5.72 and 5.76 (d×2, 1 H), 5.80 (br s, 2 H), 6.53 and 6.59 (d×2, 1 H), 7.44-7.58 (m, 6 H), 8.05-8.10 (m, 5 H).19F NMR (CDCl3, 400 MHz) δ: -198.35-198.59. 1 H NMR (CDCl 3 , 400 MHz) δ: 4.55-4.57 (m, 1 H), 4.79-4.80 (m, 2 H), 5.28 and 5.40 (d×2, 1 H), 5.72 and 5.76 (d× 2, 1 H), 5.80 (br s, 2 H), 6.53 and 6.59 (d×2, 1 H), 7.44-7.58 (m, 6 H), 8.05-8.10 (m , 5 H). ( CDCl3 , 400 MHz) δ: -198.35-198.59.
 化合物2 0.327g(0.64 mmol)をテトラヒドロフラン 3.0 mL、メタノール 1 mLに溶解後、ナトリウムメトキシド 0.069g(1.28 mmol)を添加し、1時間攪拌した。反応溶液を濃縮乾固後、カラム精製を行うことで化合物3を0.139g得た。 After dissolving 0.327 g (0.64 mmol) of compound 2 in 3.0 mL of tetrahydrofuran and 1 mL of methanol, 0.069 g (1.28 mmol) of sodium methoxide was added and stirred for 1 hour. After the reaction solution was concentrated to dryness, 0.139 g of compound 3 was obtained by performing column purification.
Figure JPOXMLDOC01-appb-C000016
Figure JPOXMLDOC01-appb-C000016
1H NMR (CD3CN, 400 MHz) δ: 3.82-3.83 (m, 2 H), 3.99-4.00 (m, 1 H), 4.20-4.22 (m, 1 H), 4.62-4.68 (m, 1 H), 5.09 (d, 1 H), 5.17 and 5.30 (t×2, 1 H), 6.37 and 6.41 (d×2, 1 H), 6.99 (br s, 2 H), 8.16 (s, 1 H).19F NMR (CD3CN, 400 MHz) δ: -198.12-198.88 1 H NMR (CD 3 CN, 400 MHz) δ: 3.82-3.83 (m, 2 H), 3.99-4.00 (m, 1 H), 4.20-4.22 (m, 1 H), 4.62-4.68 (m, 1 H), 5.09 (d, 1H), 5.17 and 5.30 (t×2, 1H), 6.37 and 6.41 (d×2, 1H), 6.99 (br s, 2H), 8.16 (s, 1H) ). 19 F NMR (CD 3 CN, 400 MHz) δ: -198.12-198.88.
(実施例2)
 化合物3 0.122g(0.4 mmol)を脱水ピリジン 3.0 mLに溶解後、4-メチルペンタノイルクロリド 0.127 mL(0.922 mmol)を添加し、16時間攪拌した。反応溶液にクロロホルムと3N HClを加えて分液した後、水洗した。このクロロホルム層を濃縮乾固した後、カラム精製を行うことで化合物4を0.145g得た。
(Example 2)
After 0.122 g (0.4 mmol) of compound 3 was dissolved in 3.0 mL of dehydrated pyridine, 0.127 mL (0.922 mmol) of 4-methylpentanoyl chloride was added and stirred for 16 hours. Chloroform and 3N HCl were added to the reaction solution for liquid separation, and the mixture was washed with water. After concentrating and drying this chloroform layer, 0.145g of compound 4 was obtained by performing column refinement|purification.
Figure JPOXMLDOC01-appb-C000017
Figure JPOXMLDOC01-appb-C000017
1H NMR (CDCl3, 400 MHz) δ: 0.88 and 0.94 (d, 12 H), 1.53-1.57 (m, 6 H), 2.34-2.43 (m, 4 H), 4.23-4.25 (m, 1 H), 4.41-4.46 (m, 2 H), 5.04 and 5.17 (d×2, 1 H), 5.31 and 5.35 (d×2, 1 H), 6.00 (br s, 2 H), 6.40 and 6.45 (d×2, 1 H), 8.03(s, 1 H)
19F NMR (CDCl3, 400 MHz) δ: -198.35-198.59
1 H NMR (CDCl 3 , 400 MHz) δ: 0.88 and 0.94 (d, 12 H), 1.53-1.57 (m, 6 H), 2.34-2.43 (m, 4 H), 4.23-4.25 (m, 1 H ), 4.41-4.46 (m, 2H), 5.04 and 5.17 (d×2, 1H), 5.31 and 5.35 (d×2, 1H), 6.00 (br s, 2H), 6.40 and 6.45 (d ×2, 1H), 8.03(s, 1H)
19 F NMR (CDCl 3 , 400 MHz) δ: -198.35-198.59
(実施例3)
 化合物3 0.122g(0.4 mmol)を脱水ピリジン 3.0 mLに溶解後、メトキシアセチルクロリド 0.084 mL(0.92 mmol)を添加し、16時間攪拌した。反応溶液にクロロホルムと3N HClを加えて分液した後、水洗した。このクロロホルム層を濃縮乾固した後、カラム精製を行うことで化合物5を0.123g得た。
(Example 3)
After 0.122 g (0.4 mmol) of compound 3 was dissolved in 3.0 mL of dehydrated pyridine, 0.084 mL (0.92 mmol) of methoxyacetyl chloride was added and stirred for 16 hours. Chloroform and 3N HCl were added to the reaction solution for liquid separation, and the mixture was washed with water. After concentrating and drying this chloroform layer, 0.123g of compound 5 was obtained by performing column refinement|purification.
Figure JPOXMLDOC01-appb-C000018
Figure JPOXMLDOC01-appb-C000018
1H NMR (CDCl3, 400 MHz) δ: 3.46 and 3.49 (s×2, 6 H), 4.11 and 4.12 (s×2, 4 H), 4.29-4.31 (m, 1 H), 4.54-4.59 (m, 2 H), 5.10 and 5.22 (d×2, 1 H), 5.42 and 5.43 (d×2, 1 H), 5.74 (br s, 2 H), 6.41 and 6.47 (d×2, 1 H), 8.05 (s, 1 H).19F NMR (CDCl3, 400 MHz) δ: -198.70-198.93. 1 H NMR (CDCl 3 , 400 MHz) δ: 3.46 and 3.49 (s×2, 6 H), 4.11 and 4.12 (s×2, 4 H), 4.29-4.31 (m, 1 H), 4.54-4.59 ( m, 2H), 5.10 and 5.22 (d×2, 1H), 5.42 and 5.43 (d×2, 1H), 5.74 (br s, 2H), 6.41 and 6.47 (d×2, 1H) , 8.05 (s, 1 H). 19 F NMR (CDCl 3 , 400 MHz) δ: -198.70-198.93.
(実施例4)
 化合物3 0.139g(0.46 mmol)を脱水ピリジン 5.0 mLに溶解後、ヘキサノイルクロリド 0.146 mL(1.05 mmol)を添加し、16時間攪拌した。反応溶液にクロロホルムと3N HClを加えて分液した後、水洗した。このクロロホルム層を濃縮乾固した後、カラム精製を行うことで化合物6を0.12g得た。
(Example 4)
After 0.139 g (0.46 mmol) of compound 3 was dissolved in 5.0 mL of dehydrated pyridine, 0.146 mL (1.05 mmol) of hexanoyl chloride was added and stirred for 16 hours. Chloroform and 3N HCl were added to the reaction solution for liquid separation, and the mixture was washed with water. After concentrating and drying this chloroform layer, 0.12g of compound 6 was obtained by performing column refinement|purification.
Figure JPOXMLDOC01-appb-C000019
Figure JPOXMLDOC01-appb-C000019
1H NMR (CDCl3, 400 MHz) δ: 0.88-0.94 (m, 6 H), 1.20-1.35 (m, 8 H), 1.50-1.70 (m, 4 H), 2.34-2.45(m, 4 H), 4.20-4.25 (m, 1 H), 4.30-4.50 (m, 2 H), 5.04 and 5.17 (d×2, 1 H), 5.32 and 5.37 (d×2, 1 H), 5.71 (br s, 2 H), 6.40 and 6.45 (d×2, 1 H), 8.03 (s, 1 H).
19F NMR (CDCl3, 400 MHz) δ: -198.35-198.60.
1 H NMR (CDCl 3 , 400 MHz) δ: 0.88-0.94 (m, 6 H), 1.20-1.35 (m, 8 H), 1.50-1.70 (m, 4 H), 2.34-2.45(m, 4 H ), 4.20-4.25 (m, 1H), 4.30-4.50 (m, 2H), 5.04 and 5.17 (d×2, 1H), 5.32 and 5.37 (d×2, 1H), 5.71 (br s , 2 H), 6.40 and 6.45 (d×2, 1 H), 8.03 (s, 1 H).
19 F NMR (CDCl 3 , 400 MHz) δ: -198.35-198.60.
(実施例5)
 2-ブロモ-6-クロロプリン 9-β-D-(2'-デオキシ-3',5'-ジ-O-ベンゾイル-2'-フルオロ)アラビノリボサイド 1.05g(1.82 mmol)をテトラヒドロフラン 1.0 mL、アンモニウム/メタノール(2 M) 6 mLに溶解後、100℃で一晩攪拌した。反応溶液を濃縮乾固後、カラム精製を行うことで化合物7を0.38g得た。
(Example 5)
2-bromo-6-chloropurine 9-β-D-(2'-deoxy-3',5'-di-O-benzoyl-2'-fluoro)arabinoriboside 1.05 g (1.82 mmol) was added to tetrahydrofuran 1.0. mL, dissolved in 6 mL of ammonium/methanol (2 M) and stirred overnight at 100°C. After the reaction solution was concentrated to dryness, 0.38 g of compound 7 was obtained by performing column purification.
Figure JPOXMLDOC01-appb-C000020
Figure JPOXMLDOC01-appb-C000020
1H NMR (DMSO-d6, 400 MHz) δ: 3.59-3.64 (m, 2 H), 3.80-3.83 (m, 1 H), 4.35-4.41 (m, 1 H), 5.03 (t, 1 H), 5.12 and 5.26 (t×2, 1 H), 5.91 (d, 1 H), 6.26 and 6.29 (d×2, 1 H), 7.85 (br s, 2 H), 8.21 (s, 1 H).19F NMR (DMSO-d6, 400 MHz) δ: -197.87-198.10. 1 H NMR (DMSO-d6, 400 MHz) δ: 3.59-3.64 (m, 2 H), 3.80-3.83 (m, 1 H), 4.35-4.41 (m, 1 H), 5.03 (t, 1 H) , 5.12 and 5.26 (t×2, 1 H), 5.91 (d, 1 H), 6.26 and 6.29 (d×2, 1 H), 7.85 (br s, 2 H), 8.21 (s, 1 H). 19 F NMR (DMSO-d6, 400 MHz) δ: -197.87-198.10.
(実施例6)
 化合物7 0.121g(0.348 mmol)を脱水ピリジン 5.0 mLに溶解後、4-メチルペンタノイルクロリド 0.105mL(0.767 mmol)を添加し、16時間攪拌した。反応溶液に酢酸エチルと3N  HClを加えて分液した後、水洗した。この酢酸エチル層を濃縮乾固した後、カラム精製を行うことで化合物8を0.195g得た。
(Example 6)
After 0.121 g (0.348 mmol) of compound 7 was dissolved in 5.0 mL of dehydrated pyridine, 0.105 mL (0.767 mmol) of 4-methylpentanoyl chloride was added and stirred for 16 hours. Ethyl acetate and 3N HCl were added to the reaction solution for liquid separation, and then washed with water. After concentrating and drying this ethyl acetate layer, 0.195g of compound 8 was obtained by performing column refinement|purification.
Figure JPOXMLDOC01-appb-C000021
Figure JPOXMLDOC01-appb-C000021
1H NMR (CDCl3, 400 MHz) δ: 0.88 and 0.94 (d, 12 H), 1.55-1.59 (m, 6 H), 2.37-2.45 (m, 4 H), 4.23-4.25 (m, 1 H), 4.39-4.46 (m, 2 H), 5.05 and 5.17 (d×2, 1 H), 5.31 and 5.36 (d×2, 1 H), 5.89 (br s, 2 H), 6.40 and 6.46 (d×2, 1 H), 8.01 (s, 1 H).
19F NMR (CDCl3, 400 MHz) δ: -198.27-198.51.
1 H NMR (CDCl 3 , 400 MHz) δ: 0.88 and 0.94 (d, 12 H), 1.55-1.59 (m, 6 H), 2.37-2.45 (m, 4 H), 4.23-4.25 (m, 1 H ), 4.39-4.46 (m, 2H), 5.05 and 5.17 (d×2, 1H), 5.31 and 5.36 (d×2, 1H), 5.89 (br s, 2H), 6.40 and 6.46 (d ×2, 1H), 8.01 (s, 1H).
19 F NMR (CDCl 3 , 400 MHz) δ: -198.27-198.51.
(実施例7)
 化合物7 0.08g(0.23 mmol)を脱水ピリジン 8.0 mLに溶解後、ヘキサノイルクロリド 0.0694 mL(0.506 mmol)を添加し、16時間攪拌した。反応溶液を濃縮乾固後、カラム精製を行うことで化合物9を0.061g得た。
(Example 7)
After 0.08 g (0.23 mmol) of compound 7 was dissolved in 8.0 mL of dehydrated pyridine, 0.0694 mL (0.506 mmol) of hexanoyl chloride was added and stirred for 16 hours. After the reaction solution was concentrated to dryness, 0.061 g of compound 9 was obtained by performing column purification.
Figure JPOXMLDOC01-appb-C000022
Figure JPOXMLDOC01-appb-C000022
1H NMR (CDCl3, 400 MHz) δ: 0.85-0.94 (m, 6 H), 1.25-1.34 (m, 8 H), 1.55-1.67 (m, 4 H), 2.34-2.41 (m, 4 H), 4.20-4.25 (m, 1 H), 4.40-4.48 (m, 2 H), 5.04 and 5.17 (d×2, 1 H), 5.32 and 5.36 (d×2, 1 H), 5.73 (br s, 2 H), 6.40 and 6.45 (d×2, 1 H), 8.01 (s, 1 H).
19F NMR (CDCl3, 400 MHz) δ: -198.26-198.50.
1 H NMR (CDCl 3 , 400 MHz) δ: 0.85-0.94 (m, 6 H), 1.25-1.34 (m, 8 H), 1.55-1.67 (m, 4 H), 2.34-2.41 (m, 4 H ), 4.20-4.25 (m, 1H), 4.40-4.48 (m, 2H), 5.04 and 5.17 (d×2, 1H), 5.32 and 5.36 (d×2, 1H), 5.73 (br s , 2 H), 6.40 and 6.45 (d×2, 1 H), 8.01 (s, 1 H).
19 F NMR (CDCl 3 , 400 MHz) δ: -198.26-198.50.
(実施例8)
 化合物7 0.16g(0.46 mmol)を脱水ピリジン 4.0 mLに溶解後、メトキシアセチルクロリド 0.092 mL(1.01 mmol)を添加し、16時間攪拌した。反応溶液にクロロホルムと3NHClを加えて分液した後、水洗した。このクロロホルム層を濃縮乾固した後、カラム精製を行うことで化合物10を0.11g得た。
(Example 8)
After 0.16 g (0.46 mmol) of compound 7 was dissolved in 4.0 mL of dehydrated pyridine, 0.092 mL (1.01 mmol) of methoxyacetyl chloride was added and stirred for 16 hours. Chloroform and 3N HCl were added to the reaction solution, and the mixture was separated and then washed with water. After concentrating and drying this chloroform layer, 0.11g of compound 10 was obtained by performing column refinement|purification.
Figure JPOXMLDOC01-appb-C000023
Figure JPOXMLDOC01-appb-C000023
1H NMR (CDCl3, 400 MHz) δ: 3.44 and 3.49 (s×2, 6 H), 4.10 and 4.15 (s×2, 4 H), 4.29-4.31 (m, 1 H), 4.54-4.60 (m, 2 H), 5.10 and 5.23 (d×2, 1 H), 5.43 and 5.47 (d×2, 1 H), 5.76 (br s, 2 H), 6.41 and 6.47 (d×2, 1 H), 8.02 (s, 1 H).19F NMR (CDCl3, 400 MHz) δ: -198.60-198.85. 1 H NMR (CDCl 3 , 400 MHz) δ: 3.44 and 3.49 (s×2, 6 H), 4.10 and 4.15 (s×2, 4 H), 4.29-4.31 (m, 1 H), 4.54-4.60 ( m, 2H), 5.10 and 5.23 (d×2, 1H), 5.43 and 5.47 (d×2, 1H), 5.76 (br s, 2H), 6.41 and 6.47 (d×2, 1H) , 8.02 (s, 1 H). 19 F NMR (CDCl 3 , 400 MHz) δ: -198.60-198.85.
(実施例9)
 化合物1 1.26g(2.98 mmol)、2-フルオロアデニン 1.10g(7.18 mmol)を脱水アセトニトリル 10 mLに溶解後、BSA 2.76 mL(8.96 mmol)を添加し、80℃で1時間攪拌した。0℃まで冷却後、トリフルオロメタンスルホン酸トリメチルシリル 1.3 mL(7.18 mmol)を添加して15分攪拌した後、再び80℃まで昇温した後、一晩攪拌した。反応溶液に飽和炭酸水素ナトリウム水溶液とクロロホルムを加えてセライトろ過後分液した。このクロロホルム層を水洗後、濃縮乾固し、カラム精製を行うことで化合物11を0.254g得た。
(Example 9)
After dissolving 1.26 g (2.98 mmol) of compound 1 and 1.10 g (7.18 mmol) of 2-fluoroadenine in 10 mL of dehydrated acetonitrile, 2.76 mL (8.96 mmol) of BSA was added and the mixture was stirred at 80°C for 1 hour. After cooling to 0°C, 1.3 mL (7.18 mmol) of trimethylsilyl trifluoromethanesulfonate was added, and the mixture was stirred for 15 minutes, then heated to 80°C again and stirred overnight. A saturated aqueous sodium hydrogencarbonate solution and chloroform were added to the reaction solution, and the mixture was filtered through celite and separated. This chloroform layer was washed with water, concentrated to dryness, and subjected to column purification to obtain 0.254 g of compound 11.
Figure JPOXMLDOC01-appb-C000024
Figure JPOXMLDOC01-appb-C000024
1H NMR (CDCl3, 400 MHz) δ: 4.55-4.57 (m, 1 H), 4.79-4.80 (m, 2 H), 5.26 and 5.39 (d×2, 1 H), 5.72 and 5.76 (d×2, 2 H), 6.47 and 6.53 (d×2, 1 H), 7.45-7.55 (m, 6 H), 8.03-8.11 (m, 5 H).
19F NMR (CDCl3, 400 MHz) δ: -50.46, -197.87-198.13.
1 H NMR (CDCl 3 , 400 MHz) δ: 4.55-4.57 (m, 1 H), 4.79-4.80 (m, 2 H), 5.26 and 5.39 (d×2, 1 H), 5.72 and 5.76 (d× 2, 2 H), 6.47 and 6.53 (d×2, 1 H), 7.45-7.55 (m, 6 H), 8.03-8.11 (m, 5 H).
19 F NMR (CDCl 3 , 400 MHz) δ: -50.46, -197.87-198.13.
 化合物11 0.25g(0.51 mmol)をテトラヒドロフラン 6.0 mL、メタノール 3 mLに溶解後、ナトリウムメトキシド 0.049g(0.91 mmol)を添加し、30分攪拌した。反応溶液を濃縮乾固後、カラム精製を行うことで化合物12を0.138g得た。 After dissolving 0.25 g (0.51 mmol) of compound 11 in 6.0 mL of tetrahydrofuran and 3 mL of methanol, 0.049 g (0.91 mmol) of sodium methoxide was added and stirred for 30 minutes. After the reaction solution was concentrated to dryness, 0.138 g of compound 12 was obtained by performing column purification.
Figure JPOXMLDOC01-appb-C000025
Figure JPOXMLDOC01-appb-C000025
1H NMR (DMSO-d6, 400 MHz) δ: 3.60-3.70 (m, 2 H), 3.78-3.81 (m, 1 H), 4.05-4.08 (m, 1 H), 4.36-4.42 (m, 1 H), 5.04 (t, 1 H), 5.11 and 5.24 (t×2, 1 H), 5.91 (d, 1 H), 6.22 and 6.26 (d×2, 1 H), 7.90 (br s, 2 H), 8.19 (s, 1 H).19F NMR (DMSO-d6, 400 MHz) δ: -50.40, -199.05-199.22. 1 H NMR (DMSO-d6, 400 MHz) δ: 3.60-3.70 (m, 2 H), 3.78-3.81 (m, 1 H), 4.05-4.08 (m, 1 H), 4.36-4.42 (m, 1 H), 5.04 (t, 1H), 5.11 and 5.24 (t×2, 1H), 5.91 (d, 1H), 6.22 and 6.26 (d×2, 1H), 7.90 (br s, 2H ), 8.19 (s, 1 H). 19 F NMR (DMSO-d6, 400 MHz) δ: -50.40, -199.05-199.22.
(実施例10)
 化合物12 0.137g(0.477 mmol)を脱水ピリジン 4.0 mLに溶解後、メトキシアセチルクロリド 0.096 mL(1.05 mmol)を添加し、16時間攪拌した。反応溶液に酢酸エチルと3N HClを加えて分液した後、水洗した。この酢酸エチル層を濃縮乾固した後、カラム精製を行うことで化合物13を0.093g得た。
(Example 10)
After 0.137 g (0.477 mmol) of compound 12 was dissolved in 4.0 mL of dehydrated pyridine, 0.096 mL (1.05 mmol) of methoxyacetyl chloride was added and stirred for 16 hours. Ethyl acetate and 3N HCl were added to the reaction solution for liquid separation, and then washed with water. After concentrating and drying this ethyl acetate layer, 0.093g of compounds 13 were obtained by performing column refinement|purification.
Figure JPOXMLDOC01-appb-C000026
Figure JPOXMLDOC01-appb-C000026
1H NMR (CDCl3, 400 MHz) δ: 3.43 and 3.48 (s×2, 6 H), 4.11 and 4.14 (s×2, 4 H), 4.31-4.32 (m, 1 H), 4.54-4.58 (m, 2 H), 5.09 and 5.21 (d×2, 1 H), 5.43 and 5.46 (d×2, 1 H), 5.74 (br s, 2 H), 6.35 and 6.41 (d×2, 1 H), 8.02 (s, 1 H).19F NMR (CDCl3, 400 MHz) δ: -50.40, -199.05-199.22. 1 H NMR (CDCl 3 , 400 MHz) δ: 3.43 and 3.48 (s×2, 6 H), 4.11 and 4.14 (s×2, 4 H), 4.31-4.32 (m, 1 H), 4.54-4.58 ( m, 2H), 5.09 and 5.21 (d×2, 1H), 5.43 and 5.46 (d×2, 1H), 5.74 (br s, 2H), 6.35 and 6.41 (d×2, 1H) , 8.02 (s, 1 H). 19 F NMR (CDCl 3 , 400 MHz) δ: -50.40, -199.05-199.22.
(実施例11)
 化合物12 0.102g(0.355 mmol)を脱水ピリジン 3.0 mLに溶解後、4-メチルペンタノイルクロリド 0.112 mL(0.817 mmol)を添加し、16時間攪拌した。反応溶液にクロロホルムと3N HClを加えて分液した後、水洗した。このクロロホルム層を濃縮乾固した後、カラム精製を行うことで化合物14を0.129g得た。
(Example 11)
After 0.102 g (0.355 mmol) of compound 12 was dissolved in 3.0 mL of dehydrated pyridine, 0.112 mL (0.817 mmol) of 4-methylpentanoyl chloride was added and stirred for 16 hours. Chloroform and 3N HCl were added to the reaction solution for liquid separation, and the mixture was washed with water. After concentrating and drying this chloroform layer, 0.129g of compound 14 was obtained by performing column refinement|purification.
Figure JPOXMLDOC01-appb-C000027
Figure JPOXMLDOC01-appb-C000027
1H NMR (CDCl3, 400 MHz) δ: 0.88 and 0.94 (d, 12 H), 1.55-1.59 (m, 6 H), 2.37-2.40 (m, 4 H), 4.20-4.25 (m, 1 H), 4.39-4.49 (m, 2 H), 5.03 and 5.16 (d×2, 1 H), 5.32 and 5.36 (d×2, 1 H), 5.81 (br s, 2 H), 6.34 and 6.40 (d×2, 1 H), 8.03 (s, 1 H).
19F NMR (CDCl3, 400 MHz) δ: -50.40, -198.64-198.90.
1 H NMR (CDCl 3 , 400 MHz) δ: 0.88 and 0.94 (d, 12 H), 1.55-1.59 (m, 6 H), 2.37-2.40 (m, 4 H), 4.20-4.25 (m, 1 H ), 4.39-4.49 (m, 2H), 5.03 and 5.16 (d×2, 1H), 5.32 and 5.36 (d×2, 1H), 5.81 (br s, 2H), 6.34 and 6.40 (d ×2, 1H), 8.03 (s, 1H).
19 F NMR (CDCl 3 , 400 MHz) δ: -50.40, -198.64-198.90.
(試験例1)
 実施例1の化合物3(1質量部)に対し製剤の副資剤(キシレン:DMF:ソルポール3005X(東邦化学工業株式会社)=4:4:1)(9質量部)を混合し、10%乳剤を作製した。展着剤グラミンS(東洋グリーン株式会社)を10000倍加用した水で所定濃度の希釈液を調製した。薬剤希釈液を各供試作物にスプレーガンにて十分量散布した。
(Test example 1)
Compound 3 of Example 1 (1 part by mass) was mixed with supplementary materials (xylene:DMF:Solpol 3005X (Toho Chemical Industry Co., Ltd.) = 4:4:1) (9 parts by mass) to give a concentration of 10%. An emulsion was prepared. A diluted solution of a predetermined concentration was prepared with water containing 10,000 times the spreading agent Grameen S (Toyo Green Co., Ltd.). A sufficient amount of the diluted drug solution was sprayed on each sample with a spray gun.
(試験例2)
 実施例10の化合物13(1質量部)に対し製剤の副資剤(キシレン:DMF:ソルポール3005X(東邦化学工業株式会社)=4:4:1)(9質量部)を混合し、10%乳剤を作製した。展着剤グラミンS(東洋グリーン株式会社)を10000倍加用した水で所定濃度の希釈液を調製した。薬剤希釈液を供試作物にスプレーガンにて十分量散布した。
(Test example 2)
Compound 13 (1 part by mass) of Example 10 was mixed with auxiliary agents (xylene:DMF:Solpol 3005X (Toho Chemical Industry Co., Ltd.) = 4:4:1) (9 parts by mass) to give a concentration of 10%. An emulsion was prepared. A diluted solution of a predetermined concentration was prepared with water containing 10,000 times the spreading agent Grameen S (Toyo Green Co., Ltd.). A sufficient amount of the diluted drug solution was sprayed on the sample with a spray gun.
病害虫の試験方法
 供試作物への薬剤の散布後、風乾し、供試虫10頭を放虫した。供試虫逃亡を防ぐため植物をカップとナイロンゴースで覆った。6日後の生存虫の数から死亡率を算出し、補正死亡率を、下記式:
 補正死亡率(%)=[(無処理区の生存率-処理区の生存率)/無処理区の生存率]×100に基づいて算出した。
Test method for diseases and pests After spraying the chemicals on the test specimen, it was air-dried, and 10 test insects were released. Plants were covered with cups and nylon gauze to prevent test insect escape. The mortality rate was calculated from the number of surviving insects after 6 days, and the corrected mortality rate was calculated using the following formula:
It was calculated based on the corrected mortality rate (%)=[(survival rate in untreated area−survival rate in treated area)/survival rate in untreated area]×100.
いもち病原菌の試験方法
 2.5葉期の幼苗に薬剤を散布処理し、いもち病罹病株と一緒に湿室にて8日間置き、病斑の形成面積を計測し、対無処理区比から防除価を、下記式(N):
 防除価=100-(処理区の被害/無処理区の被害)×100 (N)
Test method for rice blast fungi 2. Spray the drug on seedlings at the 5-leaf stage, place it in a wet room for 8 days with the rice blast-affected strain, measure the area of lesion formation, and control from the ratio to the untreated section. The value is given by the following formula (N):
Control value = 100 - (damage in treated area/damage in untreated area) x 100 (N)
紋枯病原菌の試験方法
 5葉期のイネに薬剤を散布処理し、地際に紋枯病菌(フスマ)をばらまいて湿室にて6日間置いた後、病斑の上昇を計測し、防除価を前記式(N)に基づいて算出した。
Test method for sheath blight fungi Spray the chemical on rice at the 5-leaf stage, sprinkle the sheath blight fungus (winter) on the ground, leave it in a wet room for 6 days, measure the increase in lesions, and control. The value was calculated based on the above formula (N).
炭疽病原菌の試験方法
 第一本葉完全展開期のダイズの初生葉に薬剤を散布処理し、炭疽病菌の胞子懸濁液を噴霧接種して湿室にて7日間置いた。葉上の病斑面積を計測し、防除価を前記式(N)に基づいて算出した。
Test method for anthracnose fungus Primary leaves of soybean at the stage of full development of the first true leaf were sprayed with a chemical agent, inoculated with a spore suspension of anthracnose fungus by spraying, and left in a moist room for 7 days. The lesion area on the leaves was measured, and the control value was calculated based on the above formula (N).
褐斑病原菌の試験方法
 2葉期のキュウリに薬剤を散布処理し、褐斑病菌の胞子懸濁液を噴霧接種して湿室にて8日間置いた。葉上の病斑面積を計測し、防除価を前記式(N)に基づいて算出した。
Test method for Pseudomonas aeruginosa Two-leaf stage cucumbers were sprayed with the drug, spray-inoculated with a spore suspension of Pseudomonas aeruginosa, and left in a wet room for 8 days. The lesion area on the leaves was measured, and the control value was calculated based on the above formula (N).
 試験結果を表2及び表3に示す。また、各病原菌の試験方法において、薬害も合わせて確認したが、いずれも薬害は認められなかった。 The test results are shown in Tables 2 and 3. In addition, phytotoxicity was also confirmed in the test method for each pathogen, but no phytotoxicity was observed.
Figure JPOXMLDOC01-appb-T000028
Figure JPOXMLDOC01-appb-T000028
Figure JPOXMLDOC01-appb-T000029
Figure JPOXMLDOC01-appb-T000029

Claims (13)

  1.  下記式(1):
    Figure JPOXMLDOC01-appb-C000001
    (式中、
    及びRは、それぞれ独立して、水素、1個以上の置換基を有していてもよい炭化水素基、RCO-、又はスルファモイル基であり、
    は、1個以上の置換基を有していてもよい炭化水素基であり、
    Xは、水素、ハロゲン、ニトロ基、シアノ基、1個以上の置換基を有していてもよい炭化水素基、ヘテロアリール基、RO-、RS-、又はRN-であり、
    、R、R、及びRは、それぞれ独立して、水素、又は1個以上の置換基を有していてもよい炭化水素基であり、
    Zは、水素、ハロゲン、アジド基、シアノ基、又はRO-であり、
    は、1個以上の置換基を有していてもよい炭化水素基である。)
    で表される化合物又はその塩を含有する有害生物防除組成物。
    Formula (1) below:
    Figure JPOXMLDOC01-appb-C000001
    (In the formula,
    R 1 and R 2 are each independently hydrogen, a hydrocarbon group optionally having one or more substituents, R 3 CO—, or a sulfamoyl group;
    R 3 is a hydrocarbon group optionally having one or more substituents,
    X is hydrogen, halogen, nitro group, cyano group, hydrocarbon group optionally having one or more substituents, heteroaryl group, R 4 O—, R 5 S—, or R 6 R 7 N - and
    R 4 , R 5 , R 6 and R 7 are each independently hydrogen or a hydrocarbon group optionally having one or more substituents,
    Z is hydrogen, halogen, an azide group, a cyano group, or R 8 O—;
    R 8 is a hydrocarbon group optionally having one or more substituents. )
    A pest control composition containing a compound represented by or a salt thereof.
  2.  R及びRが、それぞれ独立して、水素、又はRCO-である、請求項1に記載の有害生物防除組成物。 2. The pest control composition of claim 1, wherein R 1 and R 2 are each independently hydrogen or R 3 CO-.
  3.  Rが、1個以上の置換基を有していてもよいアルキル基である、請求項1又は2に記載の有害生物防除組成物。 3. The pest control composition according to claim 1 or 2, wherein R3 is an alkyl group optionally having one or more substituents.
  4.  Xが、水素、ハロゲン、ニトロ基、シアノ基、アルキル基、アルケニル基、アルキニル基、シクロアルキル基、アリール基、ヘテロアリール基、RO-、RS-、又はRN-であり、
    、R、R、及びRが、それぞれ独立して、水素、又は1個以上の置換基を有していてもよいアルキル基である、
    請求項1~3のいずれか一項に記載の有害生物防除組成物。
    X is hydrogen, halogen, nitro group, cyano group, alkyl group, alkenyl group, alkynyl group, cycloalkyl group, aryl group, heteroaryl group, R 4 O—, R 5 S—, or R 6 R 7 N— and
    R 4 , R 5 , R 6 and R 7 are each independently hydrogen or an alkyl group optionally having one or more substituents;
    The pest control composition according to any one of claims 1-3.
  5.  Xが、ハロゲン、シアノ基、又はRO-である、請求項1~4のいずれか一項に記載の有害生物防除組成物。 The pest control composition according to any one of claims 1 to 4, wherein X is a halogen, a cyano group, or R 4 O-.
  6.  Xが、フッ素、塩素、又は臭素である、請求項1~5のいずれか一項に記載の有害生物防除組成物。 The pest control composition according to any one of claims 1 to 5, wherein X is fluorine, chlorine, or bromine.
  7.  Zが、ハロゲンである、請求項1~6のいずれか一項に記載の有害生物防除組成物。 The pest control composition according to any one of claims 1 to 6, wherein Z is halogen.
  8.  Zが、フッ素である、請求項1~7のいずれか一項に記載の有害生物防除組成物。 The pest control composition according to any one of claims 1 to 7, wherein Z is fluorine.
  9.  前記有害生物が、植物に対する病害虫又は病原菌である、請求項1~8のいずれか一項に記載の有害生物防除組成物。 The pest control composition according to any one of claims 1 to 8, wherein the pest is a plant pest or pathogen.
  10.  前記植物が、イネ科植物、アブラナ科植物、ウリ科植物、及びマメ科植物からなる群より選択される少なくとも一種である、請求項9に記載の有害生物防除組成物。 The pest control composition according to claim 9, wherein the plant is at least one selected from the group consisting of gramineous plants, cruciferous plants, cucurbitaceous plants, and leguminous plants.
  11.  前記有害生物が、鱗翅目害虫、半翅目害虫、いもち病原菌、紋枯病原菌、炭疽病原菌、及び褐斑病原菌からなる群より選択される少なくとも一種である、請求項1~10のいずれか一項に記載の有害生物防除組成物。 Any one of claims 1 to 10, wherein the pest is at least one selected from the group consisting of lepidopteran pests, hemiptera pests, rice blast pathogens, sheath blight pathogens, anthrax pathogens, and brown spot pathogens. The pest control composition according to 1.
  12.  植物に直接施用する、又は植物を栽培する土壌に施用するための、請求項1~11のいずれか一項に記載の有害生物防除組成物。 The pest control composition according to any one of claims 1 to 11, for direct application to plants or application to the soil in which plants are grown.
  13.  下記式(1a):
    Figure JPOXMLDOC01-appb-C000002
    (式中、
    1a及びR2aは、それぞれ独立して、1個以上の置換基を有していてもよい炭化水素基、R3aCO-、又はスルファモイル基であり、
    3aは、1個以上の置換基を有していてもよい炭化水素基であり、
    は、ハロゲン、ニトロ基、シアノ基、1個以上の置換基を有していてもよい炭化水素基、ヘテロアリール基、R4aO-、又はR5aS-であり、
    4a及びR5aは、それぞれ、水素、又は1個以上の置換基を有していてもよい炭化水素基であり、
    は、ハロゲン、アジド基、シアノ基、又はR8aO-であり、
    8aは、1個以上の置換基を有していてもよい炭化水素基である。)
    で表される化合物又はその塩。
    Formula (1a) below:
    Figure JPOXMLDOC01-appb-C000002
    (In the formula,
    R 1a and R 2a are each independently a hydrocarbon group optionally having one or more substituents, R 3a CO—, or a sulfamoyl group,
    R 3a is a hydrocarbon group optionally having one or more substituents,
    X a is a halogen, a nitro group, a cyano group, a hydrocarbon group optionally having one or more substituents, a heteroaryl group, R 4a O—, or R 5a S—;
    R 4a and R 5a are each hydrogen or a hydrocarbon group optionally having one or more substituents,
    Z a is a halogen, an azide group, a cyano group, or R 8a O—;
    R 8a is a hydrocarbon group optionally having one or more substituents. )
    A compound represented by or a salt thereof.
PCT/JP2022/037122 2021-10-13 2022-10-04 Pest controlling composition WO2023063168A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021168262A JP7381913B2 (en) 2021-10-13 2021-10-13 Pest control composition
JP2021-168262 2021-10-13

Publications (1)

Publication Number Publication Date
WO2023063168A1 true WO2023063168A1 (en) 2023-04-20

Family

ID=85988575

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/037122 WO2023063168A1 (en) 2021-10-13 2022-10-04 Pest controlling composition

Country Status (2)

Country Link
JP (2) JP7381913B2 (en)
WO (1) WO2023063168A1 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5441327A (en) * 1977-09-08 1979-04-02 Nissan Chem Ind Ltd Herbicide
DE3013921A1 (en) * 1980-04-11 1981-10-22 Bayer Ag, 5090 Leverkusen Herbicidal agents contg. nucleoside derivs. - e.g. cyclo:cytidine, n-benzyl-adenosine or cytosine arabinoside
GB2284811A (en) * 1993-12-17 1995-06-21 Zeneca Ltd Herbicidal composition
GB2287464A (en) * 1993-12-17 1995-09-20 Zeneca Ltd Herbicidal composition
JPH10507063A (en) * 1994-05-20 1998-07-14 シエーリング アクチエンゲゼルシヤフト Production method of arabinonucleoside
CN105273025A (en) * 2014-07-22 2016-01-27 上海医药工业研究院 Intermediate for preparing cangrelor and preparation method and application thereof
JP2019533727A (en) * 2016-11-03 2019-11-21 ウー,ローレンス,アイ. Prodrug of clofarabine
WO2020213501A1 (en) * 2019-04-17 2020-10-22 ダイキン工業株式会社 Nucleic acid analog and anti-hepatitis b virus agent

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5441327A (en) * 1977-09-08 1979-04-02 Nissan Chem Ind Ltd Herbicide
DE3013921A1 (en) * 1980-04-11 1981-10-22 Bayer Ag, 5090 Leverkusen Herbicidal agents contg. nucleoside derivs. - e.g. cyclo:cytidine, n-benzyl-adenosine or cytosine arabinoside
GB2284811A (en) * 1993-12-17 1995-06-21 Zeneca Ltd Herbicidal composition
GB2287464A (en) * 1993-12-17 1995-09-20 Zeneca Ltd Herbicidal composition
JPH10507063A (en) * 1994-05-20 1998-07-14 シエーリング アクチエンゲゼルシヤフト Production method of arabinonucleoside
CN105273025A (en) * 2014-07-22 2016-01-27 上海医药工业研究院 Intermediate for preparing cangrelor and preparation method and application thereof
JP2019533727A (en) * 2016-11-03 2019-11-21 ウー,ローレンス,アイ. Prodrug of clofarabine
WO2020213501A1 (en) * 2019-04-17 2020-10-22 ダイキン工業株式会社 Nucleic acid analog and anti-hepatitis b virus agent

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANDERSON BRUCE G., BAUTA WILLIAM E., CANTRELL, JR. WILLIAM R., ENGLES TRACY, LOVETT DENNIS P.: "Isolation, Synthesis, and Characterization of Impurities and Degradants from the Clofarabine Process", ORGANIC PROCESS RESEARCH & DEVELOPMENT, AMERICAN CHEMICAL SOCIETY, US, vol. 12, no. 6, 21 November 2008 (2008-11-21), US , pages 1229 - 1237, XP093057995, ISSN: 1083-6160, DOI: 10.1021/op800182x *
SCACCHI, A. ; BORTOLO, R. ; CASSANI, G. ; NIELSEN, E.: "Herbicidal Activity of Dealanylascamycin, a Nucleoside Antibiotic", PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, ACADEMIC PRESS., US, vol. 50, no. 2, 1 October 1994 (1994-10-01), US , pages 149 - 158, XP024798803, ISSN: 0048-3575, DOI: 10.1006/pest.1994.1067 *

Also Published As

Publication number Publication date
JP2023162342A (en) 2023-11-08
JP7381913B2 (en) 2023-11-16
JP2023058314A (en) 2023-04-25

Similar Documents

Publication Publication Date Title
US3331735A (en) Halogenated aromatic pesticidal compositions for controlling fungi, bacteria and nematodes
JP6487426B2 (en) Process for the preparation of pest control compounds
KR100858013B1 (en) Heterocyclocarboxamide derivatives
KR100482919B1 (en) Pyrimidine-4-one derivatives as insecticides
KR20160072154A (en) Processes for the preparation of pesticidal compounds
KR20160074542A (en) Processes for the preparation of pesticidal compounds
EA026931B1 (en) Herbicidally and fungicidally active 5-oxy-substituted 3-phenylisoxazoline-5-carboxamides and 5-oxy-substituted 3-phenylisoxazoline-5-thioamides or salts thereof
KR20160072155A (en) Processes for the preparation of pesticidal compounds
KR20160075565A (en) Processes for the preparation of pesticidal compounds
EA019491B1 (en) Dithiintetracarboximides for treating phytopathogenic fungi, agents and method for treating phytopathogenic fungi based thereon and novel dithiintetracarboximides
BRPI0620513A2 (en) compost and its preparation processes, fungicidal composition and method of control of crop phytopathogenic fungi
KR20100020454A (en) Fungicide heterocyclyl-pyrimidinyl-amino derivatives
BRPI0907320A2 (en) compound and method of control of phytopathogenic fungi or weeds of plants, crops or seeds.
WO2015074614A1 (en) Pyrazole amide compound and use thereof
BRPI0616001A2 (en) phenyl amidine-derived compound and its preparation process and method of control of crop phytopathogenic fungi
CN112608307A (en) Heterocyclic ring substituted 1,3, 4-oxadiazole hydrazide compounds, and preparation method and application thereof
CN111362932A (en) Isothiazole oxadiazole amide derivatives and preparation method and application thereof
WO2023063168A1 (en) Pest controlling composition
AU2018235654B2 (en) Plant disease control agent
JP7239858B1 (en) pest control composition
Ma et al. Synthesis, herbicidal evaluation, and structure-activity relationship of benzophenone oxime ether derivatives
CN104968661A (en) Substituted amino azoles as plant growth regulators
US2475288A (en) Fungicides and insecticide
CN113024379A (en) Carbonyl-containing compound and preparation method and application thereof
CN107098869B (en) Bisamide class compound of the base of oxadiazoles containing 1,3,4- and preparation method and application

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22880864

Country of ref document: EP

Kind code of ref document: A1